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 The objective of this dissertation was to develop novel methods of patterning inorganic and 
organic materials, develop biocompatibility evaluations, and subsequently apply these methods 
toward developing biosensors and lab-on-a-chip devices, such as Interdigitated Electrodes (IDEs) 
and Microelectrode Arrays (MEAs) on non-traditional (such as nanostructured and plasmonic) 
polymer substrates or deploy these methods to enhance precision cellular placement on traditional 
(glass) MEA substrates. It was hypothesized that a combination of such facile microfabrication 
techniques and patterning technologies on traditional and non-traditional substrates would increase 
the sensitivity and selectivity of such sensor platforms by several orders of magnitude, and 
potentially introduce new modalities for cell-based biosensing. In order to demonstrate the 
biological functionality of these new IDEs and MEAs, a variety of cell cultures were used (cardiac, 
stem cell, and endothelial cells) to study the growth, proliferation, modes of increasing sensitivity 
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CHAPTER 1: INTRODUCTION 
 The objective of this dissertation was to develop facile patterning technologies for organic 
and inorganic materials such as metal layers, insulation, extracellular matrix (ECM) materials, 
micro/nanoparticles, and cells to simplify the processes and provide sensitivity/selectivity 
enhancements to these processes in order to develop cell-based biosensors, such as Interdigitated 
Electrodes (IDEs) and Microelectrode Arrays (MEAs).  The focus was on shadow or stencil mask 
fabrication technologies, 3D bioprinting techniques, and the demonstration of cell-based 
biosensors using these techniques. 
 Shadow mask (or stencil mask) fabrication technology is a fundamental component in the 
fabrication of micro/nanostructures for prototyping in microelectronics, optical, microfluidics, 
micro-electro-mechanical systems (MEMS), packaging, and biomedical lab-on-a-chip 
applications, including IDE and MEA fabrication.  Conventional shadow mask fabrication 
techniques are expensive and require cleanroom-based fabrication [1].  This factor has led to the 
demand for alternative shadow mask fabrication technologies.  Many groups have explored non-
cleanroom-based shadow mask fabrication technologies including inkjet printing of transparent 
masks [2], gravure [3], shadow mask [3], and stamping [4].  While these methods can create 
functional shadow masks, they tend to have highly limited resolution and little reusability.  
Multimodal laser micromachining, on the other hand, provides the possibility of fabricating 
shadow masks in a makerspace microfabrication environment with reduced costs, reduced 
capacity, the ability to integrate a variety of materials, one-step, non-contact processing, and 
universal applicability. Chapter 2 reports on the development of multimodal laser-based shadow 
(or stencil) masks and on the definition of organic and inorganic materials with these masks. 
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 Since the turn of the century, cell printing has gained considerable traction in the field of 
biology.  The widespread adaptation of 3D printing has revolutionized manufacturing, specifically 
in medical product design.  In the field of cellular patterning, this version of 3D printing is known 
as bioprinting.  Here biomaterials are deposited through a computer controlled dispensing system 
that places the material in designated areas with high accuracy in the micrometer scale [5].  A 
variety of 3D printing technologies have been adapted for bioprinting applications including 
powder bed fusion [6, 7], binder jetting [8], and vat photopolymerization [9], but the three main 
techniques that have proven to be most suited for bioprinting are inkjet printing, laser-assisted 
printing, and microextrusion [10, 11].  Each of these techniques has its advantages and 
disadvantages, but inkjet bioprinting is the most popular despite having some major disadvantages, 
and its less than ideal ability to translate to the clinical environment.  Laser-assisted and extrusion 
bioprinting have retained a reliance on costly commercial printing systems, which makes them far 
less attractive for already strained research budgets in academic laboratories.  Two-dimensional 
fused deposition modeling (FDM)-based cell printing, or cell plating can be a viable approach to 
enhance cell-electrode coupling in cell-based biosensors.  Considering the relatively high cost of 
human derived stem cells, cell printing can bring this additional benefit, as it reduces the cost of 
each experiment by placing cells only where they are needed. Due to the extensive printing work 
performed in this dissertation, electrogenic HL-1 cells were selected for this purpose because of 
their ability to be serially passaged. Chapter 3 further describes the rationale for this selection, as 
well as the preliminary characterization and biocompatibility testing using these cells. Chapter 4 
reports the construction and characterization of a sterile bioprinter for printing HL-1 cells and the 
characterization of droplet cellular prints using this printer. This chapter further reports on the 
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utilization of extrusion printing to precisely couple human neurons and cardiomyocytes atop 
standard MEAs and the characterization results from such assays.  
 The simplest cell-based biosensor is an IDE which has remained remarkably unchanged 
over several decades. Classic IDEs consist of two individually addressable interwoven electrode 
structures. IDEs are one of the most commonly used micro/nanosensors for chemical and 
biological sensing because of their low cost, high sensitivity, and ease of fabrication [12].  IDEs 
can easily be fashioned into a biosensor by incorporating a culture well into the design and 
attaching wires to the contact pads.  Monitoring changes in impedance of the IDEs over time allows 
for the assessment of cell growth and proliferation. IDE and impedance-based biosensors are 
currently available in the marketplace, but many of them require the use of expensive commercial 
systems [13-20] for data analysis and involve complex and expensive cleanroom-based fabrication 
approaches for micro- and nanostructuring [21] of the electrode design.  These systems often use 
densely packed electrodes, which cover much of the substrate surface, resulting in increased device 
sensitivity but prohibits the optical tracking of cells, which is required for most biological assays.  
Other approaches integrate MEAs with IDEs, which allows for more comprehensive 
measurements, but also involves a much more complex fabrication process that are not 
reproducible [22]. Additionally, they report on just electrical measures. Chapter 5 describes a new 
take on IDEs where IDEs fabricated on nanoscale substrates for dramatically enhanced 
sensitivities are reported for the first time. Further, the nanoscale substrate offers plasmonic 
sensing mode and the evaluation of this mode, as well as the characterization of the sensitivity of 
electrical, geometric, and optical modes for cell based biosensing are investigated. Up to 6 orders 
of magnitude improved sensitivity with these devices are reported. 
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 Utilizing the developed facile micro/nanofabrication technologies, such as shadow or 
stencil masking and FDM extrusion bioprinting, in this dissertation efforts have focused on truly 
revolutionizing a standard IDE and MEA cellular biosensor. As a part of this dissertation, rapid 
nanofabrication technologies have been utilized to develop IDEs on a nanostructured substrate 
with a sensing modality in addition to impedance measurement that allows for optical probing with 
plasmonics. Additionally, initial steps to develop a multimodal MEA that would allow for both 




CHAPTER 2: LASER MICROMACHINING OF SHADOW MASKS 
Laser micromachining is a direct write microfabrication technology that has several 
advantages over traditional micro/nanofabrication techniques. This chapter presents a 
comprehensive characterization of a QuikLaze 50ST2 multimodal laser micromachining tool by 
determining the ablation characteristics of six (6) different materials and demonstrating two 
applications. Both the thermodynamic theoretical and experimental ablation characteristics of 
stainless steel (SS) and aluminum are examined at 1064 nm, silicon, and polydimethylsiloxane 
(PDMS) at 532 nm, and Kapton® and polyethylene terephthalate at 355 nm. It was found that the 
experimental data aligned well with the theoretical analysis. Additionally, two applications of this 
multimodal laser micromachining technology were demonstrated: shadow masking down to 
approximately 1.5 µm feature sizes and Interdigitated Electrode (IDE) fabrication down to 7 µm 
electrode gap width. 
Hypothesis and Publications 
 Laser micromachining could be used to fabricate shadow masks with features in the single 
micron range for use in interdigitated electrodes and other Micro-Electro-Mechanical Systems 
(MEMS) applications. 
 The work presented in this chapter has previously been presented at the 22nd International 
Conference on Miniaturized Systems for Chemistry and Life Sciences (µTAS 2018) in Kaohsiung, 
Taiwan [23] and has been published in Micromachines [24]. 
Introduction 
Material ablation via pulsed light sources has been researched since the invention of the 
laser [25, 26]; however, in 1982, reports of polymers etched by ultraviolet excimer lasers launched 
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more widespread investigations into using the process for micromachining [27, 28].  In recent 
years, laser technology has been examined as an exciting material processing method for both 
industrial and academic researchers [29-32]. The high quality of laser beams allows for improved 
micromachining precision for a variety of materials [33, 34]. Additionally, the compact size, high 
efficiency, cost-effectiveness, direct machining, 3D fabrication, and ease of integration are 
appealing to academic researchers with limited benchtop area and lean budgets. 
Laser micromachining, specifically, involves the ablation of materials where the features 
produced by the laser are in the micro-scale [33, 35]. Laser micromachining techniques are 
currently employed in the automobile [36], medical [30, 37], semiconductor [38, 39], and solar 
cell industries [40]. Lasers used in micromachining are available in a wide range of wavelengths 
(ultraviolet to infrared), pulse durations (micro- to femtosecond), and repetition rates (single pulse 
to megahertz) [33, 36]. Because of this flexibility, laser micromachining allows for the processing 
of a variety of materials. 
Figure 1 compares laser micromachining to three commonly used direct-write 
microfabrication methods [41-47]. All these methods involve a mechanism for removing material 
directly from a substrate in a desired pattern using computer-controlled machinery. While other 
patterning methods, such as photolithography are often used, they are not direct-write techniques 
and involve several steps to pattern materials; thus, a comparison to these other methods is not 
provided in this figure. Photolithography is of course required for one of the methods depicted 
(Reactive Ion Etching or RIE) for performing feature definition followed by RIE to “engrave’ the 
feature in the substrate beneath [43-46]. Since RIE requires photolithography, the process involves 
more steps when compared to the other methods depicted in Figure 1 [45]. Micromilling is a 
technically simple process; however, this simplicity comes at the expense of frequent drill bit 
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brakeage and the inability to produce features in the sub-100 µm range [42]. As with some RIE 
technologies, Focused Ion Beam milling can define nanoscale features; however, the write process 
can take days depending on the pattern complexity. Additionally, in FIB-based milling processes, 
the material surface may become amorphous due to the implantation of gallium ions [41, 44-47]. 
The comparison depicted in Figure 1 is by no means comprehensive and has been included to show 
the characteristics of laser-based micromachining with some other commonly used technologies 
for patterning materials in micromachining and MEMS. Several other techniques for direct 
subtractive fabrication of micromachined features are available such as Electrical Discharge 
Machining (EDM) [48], ultrasonic drilling [49], water jet cutting [50] etc.  
The lasers used in the above-reported research can produce shadow masks for MEMS 
applications, but they are unable to micromachine highly precise features on the scale of a single 
micron, unless they operate in the femtosecond regime [31, 35, 51-54]. The higher power of these 
lasers allows for the processing of thicker materials in a more reasonable time scale; however, this 
capability comes at the price of benchtop machining, high costs, space, high power usage (GW), 
and absence of multimodality to micromachine several materials with the same tool. 
Characterization of lasers used for materials processing is necessary for the proper use of such 
tools. By understanding the necessary energy, repetition rate/frequency, spot size, and depths that 
can be micromachined with various processing conditions in specific materials, users can 




Figure 1 Comparison of three widely used direct-write fabrication methods (RIE [49, 51], micromilling [48], and FIB [47,50,53]) to laser micromachining. Each of these methods 
allows for high aspect ratio, serial, single-substrate fabrication. In the case of RIE multi-wafer/multi-substrate parallel processing is also possible as with some laser 
micromachining examples as well for higher throughput micro/nanofabrication. 
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In this dissertation chapter, the full characterization of a multimodal laser micromachining 
tool and two applications of the usage of microstructures fabricated using the tool is reported. 
Multimodal laser micromachining allows for a wide range of materials processing capabilities; 
however, this comes at the price of limited power and nanosecond ablation. These tools allow users 
to operate at specific laser wavelengths (1064 nm, 532 nm, and 355 nm, in the case of the 
QuikLaze) and reduced powers (2.6 mJ maximum energy). These conditions however provide 
greater control over the material selectivity for laser micromachining and ablation depths. 
Specifically, one can remove a material from a device while leaving the remainder of the 
constituent materials unaffected [55].   
Typically, such laser micromachining tools are employed in LCD repair, semiconductor 
failure analysis, and removing shorts and passivation layers in integrated circuits [33, 56]. In this 
chapter, the multimodal tool for the laser micromachining of six (6) different materials was 
characterized: Stainless Steel (SS) and aluminum - machined with IR mode, Polyethylene 
terephthalate (PET) and Kapton® - machined with UV mode, and Poly dimethylsiloxane (PDMS) 
and Silicon - machined with green mode. Subsequent shadow mask patterning allowed for the 
definition of organic and inorganic layers and the development of fully functional Interdigitated 
Electrode (IDE) devices. These devices are further characterized in this chapter. 
State of the Art 
 As previously stated, shadow mask, or stencil mask, technology is an integral part of the 
fabrication of micro/nanostructures in microelectronics, optical, microfluidic, MEMS, packaging, 
and biomedical lab-on-a-chip applications [57]. Typical shadow mask fabrication techniques, such 
as photolithography and deep reactive ion etching, are expensive and rely on cleanroom-based 
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fabrication, expensive vacuum equipment, ultra-pure air filtration, and advanced know-how [58-
62]. 
 Laser micromachining provides an alternative solution to these cleanroom-based 
fabrication technologies. Laser micromachining is a subtractive microfabrication technique, i.e. 
you start with a bulk piece of material and selectively remove material based on a defined design. 
The laser ablates away the substrate material in desired areas to produce a pattern. This method is 
also known as direct-write patterning. Laser micromachining offers high precision, design 
flexibility, material flexibility depending on the wavelength of laser light used, and requires no 
chemicals (harsh acids, bases etc.) to produce features in the micro and the nanoscale in a variety 
of materials. The laser can further be housed in a chemistry lab without the need for advanced 
facilities and ultra-pure air providing an intimidation-free environment for accessing and 
producing results with the tool. However, there is an inherent safety hazard from the laser light 
which can be alleviated with appropriate safety equipment. Additionally, there is an initial 
investment in laser systems, but being a one-time investment can offer advantages over other 
microfabrication technologies that require continuous investments in terms of gases, chemicals, 
mass flow controllers, etc. 
Laser micromachining has occasionally been used for shadow mask fabrication; however, 
the state of the art in laser micromachining (minimum feature size of 10 µm) [51] (to date) has 
relied entirely on single-wavelength excimer, CO2, and Nd:YAG lasers [29, 31, 40, 49, 52, 53, 63-
73]. To the best of my knowledge, multimodal laser micromachining has not been used for shadow 
mask fabrication. While the term “multimodal” in the laser field typically means that the laser 
contains multiple transverse electromagnetic modes, the laser micromachining tool used in this 
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work has the ability to operate at several wavelengths in the same tool, a rare capability not 
afforded by many lasers.  
Specifically, with respect to shadow mask microfabrication with lasers, several impressive 
research efforts are reported in literature: Tahir et. al. used a 1064 nm Nd:YAG laser to fabricate 
250 µm channels in wood, glass, plastic, and rubber [40]. Chung, et. al. fabricated shadow masks 
with minimum feature sizes of 200 µm with a 785 nm Ti: Sapphire laser [64]. Shiu, et. al. machined 
140 µm channels in low-carbon steel for use as a shadow mask using an excimer laser [71].  Yang, 
et. al. fabricated nickel shadow masks with millimeter scale features for use in pulsed laser 
deposition of thin film thermocouple sensors [74]. 
Kumar, et. al. used an excimer laser to make chromium shadow masks. They deposited a 
1000 nm layer of Cr onto a glass slide and micromilled an aluminum mask that was 10X the desired 
feature size of their final desired mask. This Al mask was then mounted to the laser and a 
demagnified image of the mask was projected over the Chrome film. This demagnified image was 
used to etch away the chromium layer and produce a shadow mask that was to be used for 2D 
lithography. This work showed a minimum feature size of 10 µm [75]. 
Fan et. al. also fabricated shadow masks using laser micromachining. Here, a CO2 laser 
was used to make wax shadow masks. The resultant mask has overly rough edges and minimum 
feature sizes of only 500 µm. In addition, these masks are not reusable [59].  
Other examples of laser micromachining feature sizes include a CO2 laser micromachined 
85 µm microfluidic channel [76], CO2 laser micromachined cuts (100-190 µm) in PMMA 
substrates [63], 10 µm microelectrode structures fabricated via excimer laser ablation [77], 10-65 
µm microdevice channels in polymeric substrates [78], 10-150 µm laser micromachined feature 
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sizes in alumina and stainless steel shadow masks [79], and 25 µm laser micromachined features 
in Permalloy for a shadow mask [80]. The lowest resolution of these efforts was limited to ~10 
µm. 
 
Figure 2 Mechanisms of ablation in laser micromachining.  Substrate removal can be a result of thermal ablation, physical 
ablation, chemical ablation, or a combination of these mechanisms. 
Microfabrication Method Overview 
In laser micromachining, a laser beam is collimated into a small spot and patterning is 
achieved by either moving the substrate within a fixed beam or rastering the laser across a surface 
[33]. The desired machining patterns simply need to be drawn in a CAD program (such as 
AutoCAD) and imported as a DXF file into the control program of the laser micromachining tool. 
Once the program is executed with the laser, substrate material removal can be a result of 
photochemical, photothermal, or photophysical ablation [81], as shown in Figure 2. Commonly 
used processes include laser cutting, scribing, drilling, or etching to produce relief structures or 
holes on a substrate in ambient temperatures [31, 36, 51, 63, 81-83]. The power of this technique 
lies in the ability to construct desired patterns on arbitrarily shaped surfaces, with the only 
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limitation being the degrees of freedom and the resolution of the motion controller. Laser 
micromachining is considered a rapid prototyping technique because designs can be changed 
immediately without the need to fabricate new molds or masks. 
Every laser micromachining system is comprised of three parts, as shown in Figure 3a for 
the multimodal laser micromachining tool: (1) the source laser, (2) the beam delivery system, and 
(3) the substrate mounting stage. Obviously, the laser source is at the heart of the system, as it 
determines which substrates and feature sizes can be micromachined [36]. The system used in this 
work has a multimodal laser source that allows for switching between three wavelengths of light: 
1064 nm infrared (IR mode), 532 nm visible green (Visible mode), and 355 nm ultra-violet (UV 
mode). This wavelength switching allows for greater substrate compatibility and a wide array of 
feature sizes in an extremely compact benchtop system.  The laser source used in this work is 
depicted in Figure 3b with greater detail. 
Beam delivery involves optical components, including fixed focusing objects and mirrors, 
galvanometric scanners, optical fibers, waveguides, apertures, and q-switches, that are used to 
focus the laser spot. The selection of these optical components depends on the working distance, 
desired spot size, and required energy [33, 36, 82, 84]. The combination of the laser source and 





Figure 3 Laser Schematic a. External schematic of a QuikLaze 50ST2 Multimodal Laser Micromachining System.  The three 
components of every laser micromachining system are shown. (1) The laser source box.  (2) The beam delivery system. (3) The 
motorized substrate mount. b. Internal schematics of the laser source box. This shows the three crystals and a switch that create 
the different wavelengths of light the system produces with the ability to switch between three wavelengths. 
Lastly, the substrate mounting system depends on how the rastering occurs on the tool. If 
the laser beam is to be rastered over the substrate surface, then a stationary substrate mount may 
be used. In most cases, including the system used in this work, it is more desirable to raster the 
substrate itself within a laser beam. In this instance, the substrate mount is manipulatable in the x- 
and y-directions, and even in the z-direction in some cases. 
In the multimodal laser system used in this work, the laser beam is initially generated as a 
1064 nm IR mode, shown in Figure 3b. The IR laser beam is subsequently passed through two 
crystals in the beam delivery system that produce the two additional wavelengths. The beam 
delivery system employs filters prior to the microscope optics to filter out the unnecessary 




A thermodynamic approach to calculating the theoretical “depth of cut” for the materials 
tested in this work was adapted from Schütz, et. al. [39]. This formula is based solely on material 
properties and laser energy. Examining the depth of cut in this manner allows for a more 
fundamental understanding of the interaction between the laser and the material with fewer 
assumptions when compared to a molecular approach used for photochemical ablation [39, 83, 
85]. 
                                             𝑎𝑎𝑝𝑝 =
𝛷𝛷





− 𝑑𝑑                                (1) 
Equation 1 shows the relationship between the depth of cut per pulse (ap), the laser fluence 
(Φ), and involved material properties, including density (ρ), vaporization temperature (Tv), heat 
capacity (cp), and the phase change enthalpy (Hvph). The d term (right-hand side of the equation) 
is a correction term that includes optical and thermal losses. This equation represented 
schematically (Figure 4) balances intrinsic energy and enthalpy, which are state variables and 
omits fundamental process parameters that are not state variables (i.e. particle dynamics) [86, 87]. 
 
Figure 4 Schematic showing the variables in the thermodynamic theory for evaluation of the depth of cut. 
While the inclusion of these fundamental process parameters could lead to a more accurate 
theoretical solution, the complexity would be vastly increased due to the use of non-linear partial 
differential equations, as well as the need for sophisticated simulation software to solve such 
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equations [33, 34, 39, 81, 85, 88]. Additionally, since this laser micromachining setup does not 
operate in the femtosecond regime, ablation occurs through melt expulsion and redeposition driven 
by the vapor pressure and the recoil pressure of light [85, 88, 89]. As a result, a simple 
thermodynamic analysis was performed to extract the relationship between the “depth of cut” and 
laser fluence which can be compared to the results obtained through experiments. 
Materials and Methods 
 This section details the materials and methods used within this chapter. 
Multimodal Laser 
A QuikLaze 50ST2 multimodal laser (New Wave Research Inc., Freemont, CA) was used 
for all the laser micromachining performed in this dissertation. A selection of three wavelengths 
as mentioned in the previous sections allows the laser to be tailored to a specific application. The 
microscope of the laser system is equipped with 10X, 50X, and 100X lenses, each with specific 
wavelength limitations. Because of additional filters in the microscope lenses, the green 
wavelength can be used through any of the lenses, while the UV and the IR can only be used 
through the 50X and 100X lenses, respectively. 
The laser outputs a 5 mm diameter Gaussian beam, which is then shaped into a rectangle 
by the XY aperture. The size of this rectangle is determined by user inputs into the control 
software. The maximum pulse duration of the laser is 5 ns for all wavelengths; however, it can be 
adjusted by the user in the program. Additionally, the laser fluence depends on the user 
specifications in the control software and the wavelength of light used, as the laser output energy 
can be adjusted by the user.  The fluence ranges from a maximum of 27,000 J/cm2 to a minimum 




To ensure a comprehensive study of multimodal laser micromachining, several materials 
were machined.  Success in laser micromachining for a given material is typically determined only 
by the choice of wavelength because each material reacts differently to a specific wavelength. In 
general, metals absorb shorter wavelengths more effectively than longer wavelengths [33, 36]; 
however, there are limitations to how effectively material is removed at shorter wavelengths 
determined by the microscope optics used. Because the amount of light transmitted through the 
microscope objectives required for each wavelength varies, the “effective” absorption of the 
material at a given wavelength is changed. 
As shown in Table 1, 12.5 µm thick Stainless Steel (type 304) (Trinity Brand Industries, 
Countryside, IL) and 16 µm thick Aluminum Foil (Reynolds Group Holdings, Auckland, NZ) were 
machined using the 1064 nm IR wavelength through the 100X microscope lens. The absorbances 
of these materials at this wavelength is 37% and 5%, respectively [61]. Kapton® of thickness 12.5 
µm (DuPont, Wilmington, DE) and 25 µm thick polyethylene terephthalate (PET) (McMaster-
Carr, Elmhurst, IL) were machined using the 355 nm UV wavelength through the 50X microscope 
lens. The absorbances of these materials at this wavelength are 22.5% and 12%, respectively [59, 
62]. Finally, Silicon (University Wafer, Boston, MA) and polydimethylsiloxane (PDMS) (Dow 
Corning, Midland, MI) were micromachined using the 532 nm green wavelength through the 10X 
microscope lens. The absorbances for these materials at this wavelength are 25% and 72%, 
respectively [17, 18, 68]. 
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Table 1 Materials characterized for use with the multimodal laser 
 
Laser Characterization 
To establish protocols for processing each material, characterization grids were machined 
for all six (6) materials. These grids consisted of 100 spots, as shown schematically in Figure 5, 
and were designed in SolidWorks (Dassault Systems, Waltham, MA). 
DXF pattern files were subsequently uploaded into the New Wave Laser program, and each 
spot was assigned a specific frequency (range of 5 Hz to 50 Hz) increasing by 5 Hz increments 
along the x-axis of the grid, and a specific energy from 10% (0.27 mJ) to 100% (2.7 mJ) increasing 
along the negative y-axis of the grid by 10%. The laser spot size was varied for each grid to provide 
full characterization of the laser’s capabilities over a wide range of fluence. Grids were then 
patterned in all 6 materials using the multimodal laser. 
All grids were imaged using Scanning Electron Microscopy (JEOL JSM-6480, Tokyo, 
Japan). Full images of the grids were obtained, as well as images of the individual spots in both 
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flat and 45º angled orientations. ImageJ (NIH, Bethesda, MD) was used to characterize the depth 
of the laser cut, as well as the resultant spot size. 
 
Figure 5 Layout of the grid of spots laser cut into the materials. The grid was designed to have 100 µm distances between the 
spots. 
Shadow Masks 
Shadow masks for the patterning of materials were fabricated from Kapton®, stainless steel, 
PET, and aluminum substrates. These materials were chosen because they are all commonly 
available in most microfabrication laboratories and it was determined that they could be ablated 
all the way through the material using the multimodal laser, a necessity for shadow masks. Full 
coverage, circle-on-line IDE shadow masks were designed using SolidWorks and machined using 
the multimodal laser and the appropriate wavelength for the substrate material. The shadow masks 
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were then imaged using the SEM (JEOL JSM-6480, Tokyo, Japan) to characterize the design 
(CAD dimensions) to device (fabricated shadow mask) translation. These shadow masks were 
subsequently used to pattern both metal and gelatin for design to device studies, as described 
below. 
Additionally, traditional interwoven comb IDE shadow masks were fabricated to test the 
lowest feature size limits of the multimodal laser. These structures allow for more rapid shadow 
mask fabrication at the lowest possible widths ensuring higher sensitivity in IDE assays; thus, 
allowing for any necessary adjustments to achieve the desired electrode gap width. Due to the size 
of these structures, Atomic Force Microscopy (AFM) (Anasys Instruments, Santa Barbara, CA) 
and SEM (JEOL, Tokyo, Japan) were used to characterize the electrode gap widths of these 
shadow masks. 
Lastly, because of the widespread use of PDMS in microfluidics, several lines of 2 mm 
length were laser micromachined into this material to determine the depth of cut for a given number 
of laser passes. All lines were micromachined through the IR microscope lens with the green laser 
at 2.7 mJ with an X-Y aperture area of 50 µm2. The number of laser passes was varied from 5 to 
40 passes. In this mode of operation, the laser beam is continuously scanned across the surface of 
the material in the desired pattern. 
The process flow for the shadow mask fabrication and subsequent patterning of organic 
and inorganic layers is depicted in Figure 6. 
Patterning of Organic and Inorganic Layers 
To access the accuracy of low power, multimodal laser micromachining, material 




Figure 6 Schematic of laser micromachined shadow mask fabrication and subsequent materials patterning demonstration. 
Gelatin Patterning 
Gelatin (Millipore Sigma, St. Louis, MO) and deionized (DI) water were mixed to make a 
5%-wt. gelatin solution to act as a sample bioink. Kapton® IDE shadow masks were dipped in DI 
water to allow for better adherence to the glass microscope slide substrates. The 5%-wt. gelatin 
solution was subsequently pipetted onto the glass slides through the shadow masks. The gelatin 
solution was allowed to set, then the shadow masks were carefully removed to expose the gelatin 
IDE patterns. The resultant gelatin structures were imaged using a Nikon TS2 inverted microscope. 
Metal Patterning 
The Kapton®, stainless steel, aluminum, and PET multimodal laser micromachined shadow 
masks were affixed onto glass microscope slides (Fisher Scientific, Hampton, NH) with Kapton® 
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tape (DuPont, Wilmington, DE). Titanium-Gold (Ted Pella, Redding, CA) electrodes, traces, and 
contact pads of 5 nm-30 nm thickness respectively were subsequently deposited (Deposition rate: 
1 Å/sec at 1 x 10-6 Torr) through these shadow masks onto glass microscope slides via electron 
beam evaporation (Thermionics, Port Townsend, WA). After metal patterning, the shadow masks 
were removed by carefully detaching the Kapton® tape from the glass slide with tweezers. 
Transmitted light microscopy (TS2 Inverted Microscope, Nikon, Tokyo, Japan) was used to image 
the patterned metal structures. ImageJ (NIH, Bethesda, MD) was used for further optical analysis 
of the captured images and measurement of the electrode structures. 
Impedance Characterization of Metal Patterns 
The full frequency spectrum impedance of each of the resultant patterned metal IDE 
structures was measured with a BODE 100 impedance measurement system (Omicron Labs, 
Klaus, Austria) in series-thru impedance measurement mode, as shown in Figure 7.  Series-thru 
organization of the system was chosen because the impedance of the sensors exceeded 1 kΩ at all 
frequencies, meaning that the impedance is in the mid-to-high range that is ideal for this 
measurement setup.  The measurement is swept through a frequency range of 10 Hz to 10 MHz 
with the voltage ranging from 14 mV to 2 V depending on the frequency. 
Dulbecco’s phosphate buffered saline (DPBS) (Gibco, Waltham, MA) acted as the 
electrolyte solution and Platinum-Titanium wire (eDAQ, Deniston East, NSW, Australia) was used 
as a counter electrode used during the impedance measurements. Impedance data was extracted 




Figure 7 Schematic of a Series-Thru impedance measurement on the Bode 100.  
 
Figure 8 SEM images of the laser characterization grids for each of the six materials. Kapton®, SS, PET, and aluminum are all 
at the maximum spot size for their respective wavelengths. Silicon and PDMS are both at 50% spot size to show the grid in its 
entirety. All scale bars are 200 µm. 
Results and Discussion 
 Here, we present and discuss the results of the experiments. 
Laser Characterization 
Laser characterization grids were fabricated for each of the six materials for a range of spot 
sizes as described in Materials and Methods section. The spot sizes for the materials depended on 
the microscope objective that was used for the ablation. The spot sizes ranged from 50 µm down 
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to 2 µm for IR ablation through the 100X lens for stainless steel and aluminum, 60 µm down to 4 
µm for UV ablation through the 50X lens for Kapton® and PET, and 250 µm down to 20 µm for 
green ablation though the 10X lens for silicon and PDMS. SEM imaging of these grid structures, 
and subsequent processing in ImageJ was used to calculate the depth of cut for each spot 
micromachined by the laser. Figure 8 shows examples of the characterization grids for each of the 
six materials at the maximum spot size for each wavelength. For PET, Kapton®, stainless steel, 
and aluminum, full ablation (through vias, all the way through the substrate) is achieved for the 
full range of power and frequency combinations shown in Figure 5. Since these materials were 
fully ablated within the 10 pulses used, the ablation depth was averaged over the number of spots. 
Some deviation from the theoretical calculation for these materials was observed. Ablation rates 
of 46.3 µm/mJ for Kapton® and stainless, 92.6 µm/mJ for PET, and 59.3 µm/mJ for aluminum 
were achieved. Neither silicon nor PDMS were able to be fully ablated through for any power and 
frequency combination. Silicon began measurable ablation at a minimum of 35 Hz and 2.43 mJ 
and had an ablation rate of 1.4 µm/mJ. PDMS began measurable ablation at a minimum of 35 Hz 
and 2.16 mJ, which gives an ablation rate of 1.5 µm/mJ. 
Traces (lines) were scribed in PDMS using the green laser through the IR lens with between 
5 and 40 passes and a 50 µm laser spot size. Cross sectioning the scribed lines carefully using a 
razor blade, followed by SEM imaging of the cross section, resulted in the measurement of the 
depth of cut for each number of laser passes. Figure 9 shows the linear relationship that was found 
between the depth of cut and the number of laser micromachining passes. Characterizing this 
relationship allows for the fabrication of microchannels of specific depths in PDMS by varying 




Figure 9 Results from scribing lines in PDMS with a varied number of laser passes. The depth of cut increases linearly with the 
number of laser passes as expected. This allows for the direct tuning of channel depth by selecting the number of passes the laser 
makes to cut PDMS. 
Comparison to Theoretical Values 
Figure 10 and Table 2 show the comparison between the theoretical ablation depth model 
and the experimental results. For silicon and PDMS, the thermodynamic model fits well. The 
comparison in ablation depth per pulse for both materials between theory and practice is in the 
same order of magnitude. Further, the ablation depth per pulse/ depth of cut plots for both materials 
show a clear correlation between the experimental and theoretical data. Neither one of these 




Figure 10 Comparison of theoretical and experimental ablation depth for a range of fluences in silicon. 
Conversely, deviation from theory is observed in the experimental ablation depth per pulse 
comparison for Kapton®, stainless steel, PET, and aluminum. Kapton® and stainless steel perform 
similar to silicon and PDMS as observed in Table 2 with both the theoretical and experimental 
values in the same order of magnitude with experimental values being smaller than theoretical 
values. The discrepancy between PET and Aluminum is roughly an order of magnitude higher 
predicted theoretical values. The laser ablated through these materials at some point (difficult to 
measure experimentally in our current setup), so deviation is expected in all these materials. For 
example, both Kapton® and stainless steel could have shown an average ablation depth of ~3 µm 
per pulse, and both PET and aluminum could have shown an average ablation depth of 
approximately ~16 µm per pulse. Because of the thickness of these materials, when the 
normalization of the ablation depth to the number of pulses is performed, the experimental values 
are determined to be substantially lower. The key results from the experimental data in this case is 
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that the laser is capable of fully ablating these thicknesses and that a reasonable number of pulses 
can be used to ablate even thicker samples of these materials. These results also show the 
limitations of a thermodynamic approach, as the material thickness is not considered in the 
calculations. 




Two applications of this multimodal laser micromachining technique were additionally 
demonstrated in this work namely the microfabrication of shadow masks and IDEs. 
Shadow Masks 
Shadow masking technology is an integral part of fabricating micro/nanostructures for 
prototyping in microelectronics, optical, microfluidic, Micro-Electro-Mechanical Systems 
(MEMS), packaging, and biomedical lab-on-a-chip applications [38, 51]. Typical methods for 
producing shadow masks, such as photolithography and Deep Reactive Ion Etching (DRIE) or Ion 
Beam Milling, are expensive, require cleanroom-based fabrication, expensive vacuum equipment, 
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ultra-pure air filtration, and advanced know-how [1, 31]. Multimodal laser micromachining, on 
the other hand, is simple, cost effective, and makerspace-compatible, all vital attributes for cell-
based assays and microfluidics applications. 
 
Figure 11 Images of sub-5 µm trace widths in Kapton®. a. AFM image of 3.5 µm trace width (white area). b. AFM image of 1.5 
µm trace width (white area). c. SEM image of full comb finger electrode structure (approx. 5 µm trace width). d. SEM image of 
shadow mask feature of approximately 2.43 µm trace width. 
Fabrication of the shadow masks down to ~1.5 μm was successfully demonstrated, as 
shown in Figure 11. To the best of my knowledge, this is the lowest feature size demonstrated for 
laser defined shadow masks [31, 51]. Previous work with laser micromachining has produced 
feature sizes down to ~10 μm. As a result, patterns that are an almost an order of magnitude better 
than the state of the art are reported in this dissertation. 
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Patterning Through Shadow Masks 
The laser micromachined shadow masks were further used to pattern both metal and 
gelatin/bio-ink. The organic and inorganic layer patterning can be utilized for applications such as 
accurate cell placement in single cell and culture assays, precision confinement and growth of 
cellular constructs, tissue engineering, metal micro/nanoelectrodes, definition of organic insulation 
layers, and other lab-on-a-chip and diagnostic applications [31, 51, 82, 90, 91]. 
 
Figure 12 Design to shadow mask to device (IDE on glass) for the four materials that cut all the way through the substrate.  a. 
Stainless steel to Ti-Au metal IDE, b. Kapton® to gelatin IDE pattern, c. Aluminum to Ti-Au metal IDE, and d. PET to Ti-Au 
metal IDE. 
Design of a shadow mask to microfabricated device translation for the four materials that 
the multimodal laser was completely able to micromachine through are shown in Figure 12. 
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Aluminum, PET, and stainless-steel shadow masks were used to fabricate metal IDEs while 
Kapton® shadow masks were used for fabricating a gelatin/bio-ink IDE. It was observed that 
Kapton® and stainless steel demonstrated the best design to device translation for 125 µm to 7 µm. 
Both stainless steel and Kapton® showed minimal thermal damage from laser microfabrication at 
their respective laser wavelengths (1064 nm and 355 nm). Additionally, both materials have 
coefficients of thermal expansion (both approximately 20 x 10-6 K-1) which are 2x larger than the 
thermal expansion of glass (9 x 10-6 K-1) [46] theoretically suggesting better translation results and 
experimentally verified in Figure 12 (for N = 3 measurements at the various design values). The 
best design to device translation was observed to be ~98% for the 7 µm gelatin features due to the 
rapid deposition and curing of the gelatin. The worst design to device translation for stainless steel 
was observed to be 95% for 125 µm metal IDE on glass due to the higher run-off possibilities 
during the electron beam evaporation process [34]. PET and aluminum demonstrated a deviation 
from the designed IDE pitch by 11.2% and 25.8% at maximum pitch, respectively. PET has a 
coefficient of thermal expansion (80 x 10-6 K-1) [87] that is nearly an order of magnitude larger 
than that of glass, so some deviation from the design dimensions is expected due to thermal 
mismatch effects during e-beam evaporation. The aluminum shadow mask exhibited physical 
melting during the laser micromachining process, which could explain the large deviation from 
design dimensions. 
Figure 13 shows the design schematic, SEM images of the shadow masks, and transmitted 
light microscope images of both Ti-Au metal patterning and gelatin bioink patterning for circular 
fill IDE patterns with electrode gaps from 125 µm to 7 µm. Metal patterning appeared to work best 
with Kapton® or stainless-steel shadow masks because their coefficients of thermal expansion are 
closer to that of glass. Kapton® and PET shadow masks worked best for gelatin patterning. Both 
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shadow mask materials allowed for simple adhesion to the glass substrate utilizing surface tension 
effects by simply dipping the mask in DI water prior to attachment on glass substrates. Allowing 
the gelatin to fully set prior to shadow mask removal was key in preventing the patterns from 
bleeding. 
 
Figure 13 Results of laser micromachining of the shadow masks, as well as inorganic and organic layer patterning. The design of 
an Interdigitated Electrode (IDE) was translated into metal (titanium-gold) and bioink (gelatin). 
The impedance of the metallized IDEs (Figure 14) was found to decrease with decreasing 
electrode gap width as is expected [92] with the 1 kHz impedance decreasing by 33.47% between 
the extremities of the designs tested. Table 3 further illustrates impedances at key frequencies, 
clearly depicting resistive behavior at the lower and upper ends of the spectra and capacitive 




Figure 14 Full spectrum impedance measurements of several IDEs of varying pitch.  The electrophysiologically significant 
frequency of 1 kHz (green line) reports impedances from approximately 39 kΩ (7 μm) to 56 kΩ (62 μm). 





Complete characterization of the laser micromachining processes for six (6) commonly 
used microfabrication materials was developed in this chapter using a multimodal laser 
micromachining tool. Characterization of the QuikLaze 50ST2 multimodal laser for the laser 
micromachining of six (6) different materials demonstrated that the ablation depth that were 
experimentally obtained fit relatively well with a simple thermodynamic theory for most of the 
materials. While more complex theories or analysis [88] one could improve the discrepancy, this 
technique is accurate enough to allow one to readily calculate possible ablation depths of a new 
material using such a laser micromachining tool. Additionally, two applications of multimodal 
laser micromachining were demonstrated: shadow mask fabrication in the sub-5 µm range and 
patterning of organic and inorganic materials in the sub-10 µm range. The ability for such a 
technique which allows for rapid prototyping of shadow masks and devices, combined with the 
compact, benchtop-friendly design gives multimodal laser micromachining tremendous promise 




CHAPTER 3: HL-1 CELL LINE ESTABLISHMENT AND MATERIAL 
BIOCOMPATIBILITY 
 The work presented in this chapter has been published in Biosensors in October 2020 [93]. 
This cell line also helped the group to report on its first electrophysiological data acquisition from 
a 3D Microelectrode Array (3D MEA), which was the subject of a paper accepted in RSC 
Advances in November 2020 [94] and a presentation in NanoFlorida 2019 [95]. 
Introduction 
 Since the development of cell-based biosensors was the focus of the work in this 
dissertation, preliminary cell studies were needed.  Initially, the idea was to rely on collaborators 
(such as Prof. Hickman) for the cell studies and some of these collaborative results are presented 
in the bioprinting chapter. Two things became evident as the facile biosensor 
micro/nanofabrication methodologies were developed: (1) bioprinting on cell-based biosensors 
required a lot of cell experiments; (2) biocompatibility of materials being used in the biosensors 
was paramount and needed specific attention. As a result, it was decided to pursue a separate cell 
line in the lab to facilitate these experiments. 
 Since a majority of in vitro biosensor research focuses on human induced pluripotent stem 
cells [14, 16, 90, 96-98], specifically cardiomyocytes, this was where the cell studies had originally 
focused. The requirements for handling and costs of these cells were researched and found to be 
beyond what was required in this dissertation [99]. Additionally, further increase in cellular 
population, known as passaging, is not possible with these cells [98].  The original idea was that 
any intermittent testing could be done with lower overheads of handling, care, and costs with 
human induced pluripotent stem cell derived retinal pigment epithelial cells.  While these cells 
were not electrogenic, they grew rapidly and, in a brick-like pattern, which quickly allowed for 
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identification of any biocompatibility, impedance changes, or process issues that may have been 
present. 
 As the work in this dissertation progressed, it became clear that extensive cell experiments 
with passaging of a cell line would be needed.  The promising results presented in the nIDE chapter 
which follows later, as well as the cell consumption involved with developing a bioprinter made it 
clear that we would need to establish a cell line in our lab. 
To test material biocompatibility, a cell type that has been well studied and has predictable 
growth patterns should be used.  HL-1 cells are derived from rat atrial cardiac myocytes and are 
the only cardiomyocyte cell line currently available that can continuously divide, spontaneously 
contract, and maintain a differentiated adult cardiac phenotype [100, 101].  Additionally, this cell 
line has been widely characterized using optical, electrophysiological, immunohistochemical, and 
pharmacological methods [100, 101]. 
 
Figure 15 Fluorescent microscopic images taken from Peter et. al. of the three most employed cardiomyocytes.  a. Neonatal rat 
ventricular myocytes:  the immaturity of the cells can be seen when compared to the b. HL-1 cells and c. human induced 
pluripotent stem cell derived cardiomyocytes. [102] 
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Cell Line Selection 
 Several decisions were to be made when choosing a cell line to establish in the lab.  Since 
we were interested in morphological and electrophysiological measures, electrogenic cells 
addressed all our needs. A choice was subsequently made between neurons and cardiomyocytes.  
Cardiomyocytes tend to be slightly easier to manage [103, 104], which was ideal for our lab since 
cell biology experience was minimal and not the focus of the lab.  Three cardiomyocyte cell types 
are commonly used in biosensor research: the aforementioned human induced pluripotent stem 
cell derived cardiomyocytes (hiPSC-CM), neonatal rat ventricular myocytes (NRVM), and HL-1 
cells [104, 105]; and a decision needed to be made about which cell line would be the best choice 
for our needs.  Figure 15 shows fluorescent microscope images from Peter et. al. comparing the 
three cell types [102]. 
 The first cell type of the three is the most popular, and the ideal choice as far as clinical 
translation, human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs).  These are 
intrinsically heterogeneous consisting of three subpopulations: atrial-, ventricular-, and nodal-like 
cardiomyocytes [106, 107].  This is beneficial because these cell types are all present in the heart, 
meaning that any drug dosing experiments give a more realistic picture of potential reactions.  
Additionally, these cells are human, which means that direct clinical translation of drugs is easier 
to realize as reactions are human [102, 106].  These cells also set the tone for future “personalized” 
medicine where cells from a patient can be used to determine any potential side effects or reactions 
to treatments. 
 While hiPSC-CMs are the ideal choice, some significant downsides still exist. Despite the 
successful differentiation of human induced pluripotent stem cells into spontaneously beating cells 
with active cardiogenic marker genes, the resulting cardiomyocytes are an immature and highly 
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variable cardiac phenotype [107].  Electrophysiology measurements have shown that the shapes 
of the action potentials have varied significantly between studies and even within studies among 
the same cell lines (derived from a different set of stem cells) and with different differentiation 
methods [106].  An example of these different action potential morphologies, from He, et. al. is 
presented in Figure 16 [98].  This high heterogeneity requires that many cells be analyzed to 
generate statistically meaningful conclusions.  The high cost of stem cell derived cardiomyocytes 
makes maintaining such a cell line for a non-biology-based lab prohibitive. 
 
Figure 16 Different shapes of action potentials that can be generated from stem cell-derived cardiomyocytes [98] 
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 Because human cells were not realistic for our needs, animal models needed to be explored.  
There is no ideal animal model available for cardiac research [108].  The use of every animal 
model is accompanied by its own set of advantages and disadvantages.  Many disadvantages come 
in the form of ethical questions of the use of animals that many consider pets in laboratory settings.  
For this reason, only rodent models were considered, as people are generally more inclined to 
accept this.  Cardiac excitation, contraction, and relaxation of small rodents and humans many 
similarities (Figure 17) [102, 106, 108-111].  Both groups express proteins with similar functions 
and roles [108, 110].  Genetically modified mouse and rat models can be used to probe the function 
of various genes in cardiac physiology and disease, which can address vital questions in physiology 
and disease modelling.  Despite their similarities, there are important differences in human and 
small rodent models, mouse/rat models allow for rapid establishment of proof-of-principle that can 
later be extended to human models [108]. 
 
Figure 17 Comparison of action potentials for human and mouse derived cardiomyocytes.  The action potentials are of similar 
amplitude, but the pulse duration differs by an order of magnitude.  From Lin et. al. [106] 
 Neonatal rat ventricular myocytes (NRVM) solve some of the issues with hiPSC-CMs 
[104, 105].  They are all ventricular-like, which means that the action potentials that they exhibit 
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are homogeneous [103].  These cells are primary cardiomyocytes meaning they are terminally 
differentiated cells and they are difficult to transfect [102].  While you can purchase primary cells 
from several companies, it is much more economical to procure them yourself directly from the 
rat [102].  This brings in a whole host of new institutional and ethical protocols since it involves 
live animals, as well as the need for expensive new equipment.  Additionally, their use is somewhat 
limited because they lack many adult cardiomyocyte characteristics, such as becoming overgrown 
by non-myocytes after a few days in culture, ceasing to divide after the neonatal period, and 
difficult genetic manipulation [102, 108, 110]. 
 HL-1 cells were the third option.  The HL-1 cell line was derived from AT-1 cardiac 
myocytes, which are atrial cardiac muscle cells obtained from transgenic mice in which the 
expression of the SV40 large T antigen was controlled by the atrial natriuretic factor (ANF) 
promoter [100, 101].  These cells can continuously divide, spontaneously contract, and maintain a 
differentiated adult cardiac phenotype through indefinite passages in culture [100, 101].  HL-1 
cells have been characterized using microscopic, immunohistochemical, electrophysiological, and 
pharmacological methods [101].  The cells contain highly organized sarcomeres necessary for 
mediating contraction and intracellular ANF granules characteristic of atrial myocytes [101, 102, 
106].  Additionally, they exhibit an adult cardiomyocyte-like gene expression profile, meaning 
that they should respond to chemical stimulation as typical adult cardiomyocytes would [101, 102, 
106].  HL-1 cells spontaneously depolarize and express the necessary ion channels required for 
generating action potentials characteristic of primary cardiomyocytes [101], which makes them a 
good candidate for electrophysiological experiments.  Some disadvantages of HL-1 cells include 
their rapid uninhibited growth and their homogeneous atrial phenotype makes the cell line 
incompatible with ventricular studies [101, 102, 106]. 
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 Table 4 lays out the advantages and disadvantages of these cell lines [101, 102, 106, 108].  
Because of the frequency of cell culture in our lab (often, but not continuous), HL-1 cells seemed 
to be the optimal choice.  The low cost and maintenance of this cell line combined with the 
possibility for serial propagation gave the flexibility to bank billions of cells for future use to be 
thawed as needed.  Additionally, we already had much of the required labware.  The support for 
the cell line as well as a BioCane for cryogenic storage came from a generous UCF Doctoral 
Research Support Award provided by CECS. 
Table 4 Comparison of the advantages and disadvantages of the three most common cardiomyocyte cultures used in the 
biosensor community 
 
Materials and Methods 
 In this section of the chapter, the methods for establishment of the cell line and 
biocompatibility testing of the cells follow. 
Establishment of HL-1 Cell Line and Protocols 
 HL-1 cells were purchased from Millipore Sigma.  The cells arrived in a cryovial and were 
immediately thawed into prepared cell culture flasks.  The following sections detail the protocol 
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for thawing, passaging, and freezing the cells, as well as the recipes for the various mediums 
needed for these protocols.  All protocols and recipes were adapted from Dr. Claycomb’s original 
paper and one that followed [100, 101].  Everything has been adapted to fit the specific needs of 
our lab without sacrificing the health of the HL-1 cells.  Significant trial and error have allowed 
for the development of this protocol.  The initial establishment of the cell line required nearly 24/7 
lab work, which was thankfully shared with my colleague Dr. Frank Sommerhage.  By combining 
our time, we were able to establish an impressive cell bank, as well as determine to nearly the half-
hour when we could expect the number of cells to have doubled.   
Prior to starting the cell experiment, the centrifuge, water bath, and microscope were all 
turned on.  Additionally, the IPA/Ethanol bottle was filled, and the inside of the biosafety cabinet 
was been sprayed and wiped down.  Finally, it was determined that all needed consumables were 
present inside the biosafety cabinet.   
Most of the solutions used in culturing the cells required pre-mixing or aliquoting. 
Gelatin/Fibronectin Solution 
 To make gelatin/fibronectin solution, 10 mL of 0.1% gelatin solution were added to 40 mL 
of sterile water in a 50 mL centrifuge tube.  This made a 0.02% gelatin solution.  250 µL of 
fibronectin (1 mg/mL) was added to the 50 mL centrifuge tube of 0.02% gelatin solution and mixed 
gently.  The mixture was then sterile filtered using a 0.2 µm syringe filter aliquoted into 15 mL 
centrifuge tubes.  Aliquots were kept frozen at -20°C. 
Norepinephrine 
 To make 10 mM stock norepinephrine, 0.59 g of ascorbic acid was added to 100 mL of cell 
culture grade distilled water (30 mM ascorbic acid).  Then 80 mg of norepinephrine was added to 
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25 mL of the 30 mM ascorbic acid and filter sterilized using a 0.2 µm syringe filter.  The solution 
was then aliquoted into 1 mL working volumes in sterile microtubes and stored at -20°C.  1 mL of 
stock solution was used per 100 mL of Claycomb medium for a final concentration of 0.1 mM of 
norepinephrine. 
L-Glutamine 
L-glutamine came as a 100X solution.  It was aliquoted into working volumes in sterile 1 
mL microtubes and stored at -20°C. 
Supplemented Claycomb Medium 
Supplemented Claycomb Medium was required to maintain the desirable characteristics 
(beating, differentiation, phenotype) of HL-1 cells.  To make supplemented Claycomb medium in 
working volumes for our needs, 87 mL of Claycomb medium, 10 mL of Fetal Bovine Serum, 1 
mL of penicillin/streptomycin, 1 mL of 10 mM stock norepinephrine, and 1 mL of L-Glutamine 
were mixed to make 100 mL of medium.  The medium was stored in amber glass media bottles 
and protected from light at 4°C. 
Wash Medium 
 Wash medium was used to wash the cells of trypsin and trypsin inhibitor or freezing 
medium during centrifuging by supplying them with necessary nutrients they may have been 
lacking for a short time.  To make 100 mL of wash medium, 94 mL of Claycomb medium, 5 mL 
of fetal bovine serum, and 1 mL of penicillin/streptomycin were mixed in a glass amber media 
bottle and protected from light.  Wash medium was stored at 4°C. 
Freezing Medium 
 Freezing medium was used for cryogenic storage of cells.  To make freezing medium, 9.5 
mL of fetal bovine serum was mixed with 500 µL of dimethyl sulfoxide (DMSO) in a 15 mL 
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centrifuge tube.  DMSO was used to prevent the formation of ice crystals during the freezing 
process, which would kill the cells. 
Soybean Trypsin Inhibitor 
 Soybean trypsin inhibitor was necessary to stop the trypsinization of cells in culture.  It 
was necessary to use trypsin to remove the cells from the surface from which they were adhered, 
but if the action of the trypsin was not halted, the cell surface proteins would begin to be digested 
and cell functioning would be impacted. 
 To make soybean trypsin inhibitor, 25 mg of soybean trypsin inhibitor was weighed out 
and placed into a beaker containing 100 mL of phosphate buffered saline.  The solution was mixed 
until the soybean trypsin inhibitor was dissolved.  The solution was then filter sterilized using a 
0.2 µm syringe filter and placed into a 50 mL centrifuge tube.  Soybean trypsin inhibitor was stored 
at 4°C for up to 1 month. 
Pre-Coating Flasks with Gelatin/Fibronectin Solution 
 The required number of frozen 15 mL tubes of gelatin/fibronectin solution were thawed in 
the 37°C water bath.  Once thawed, sterile tissue culture flasks were coated with the required 
volume of the gelatin/fibronectin solution.  T25 flasks required 1 mL and T75 flasks required 3 
mL.  The flasks were capped and incubated at 37°C for at least one hour, preferably overnight.  
The gelatin/fibronectin solution was removed from the flask via aspiration just prior to adding the 
cells. 
Initial Cell Culturing and Banking of Cells 
 Two T25 flasks were prepared for cell culture using the coating protocol above.  The 
gelatin/fibronectin solution was aspirated from the culture flasks and replaced with 4 mL of 
supplemented Claycomb medium in each flask.  The flasks were placed back in the incubator.  A 
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volume of 10 mL of wash medium was added to an empty 15 mL centrifuge tube and incubated in 
a 37°C water bath.  The cells were quickly thawed in the 37°C water bath (approximately 2 
minutes).  The cells were immediately transferred to the 15 mL centrifuge tube containing the 
wash medium and centrifuged for 5 minutes at 500 x G.  When centrifuging was complete, the 
tube was removed from the centrifuge and the wash medium was aspirated while being careful not 
to disturb the cell pellet.  The cell pellet was resuspended in 2 mL of supplemented Claycomb 
medium.  1 mL of the mixture was transferred into each of the two culture flasks.  The medium in 
each flask was replaced with 5 mL of fresh medium approximately 4 hours later after the cells had 
attached.  Figure 18 presents this procedure sequentially with optical images. 
 
Figure 18 Schematic of the process for thawing and plating HL-1 cells. 
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 After the cells first arrived, it was recommended that they were split when they reached 
confluency, that was when most of the surface became covered with cells.  Each of the T25 flasks 
was split 1:2, which resulted in four T25 flasks.  
 When the cells became confluent, they needed to be passaged to proceed further.  The 
procedure for passaging cells from a T25 flask follows and is shown in Figure 19.  First, medium 
was aspirated from the flasks.  A volume of 3 mL of DPBS warmed to 37°C was added to each 
flask by pipetting the DPBS onto the base of the flask (the side opposite the cap) trying not to 
injure the cells.  The cells were rinsed gently and the DPBS was removed via aspiration.  Next, 1 
mL of pre-warmed 0.05% trypsin/EDTA was added to each flask and incubated at room 
temperature for 1 minute.  The trypsin was then removed and fresh 0.05% trypsin/EDTA was 
added and incubated at room temperature for an additional 2 minutes.  The flasks were then 
examined microscopically to confirm that cells were detached, as shown in Figure 20.  If the cells 
were still adhered, the flask was gently perturbed with hands on the benchtop to dislodge the 
remaining cells.  To inactivate the remaining trypsin, 1 mL of soybean trypsin inhibitor was added 
to the flask.  Cells and solution from the flask were transferred to a 15 mL centrifuge tube.  The 
empty flask was rinsed with 5 mL of wash medium, which was then aspirated and added to the 
cells already in the 15 mL centrifuge tube.  The total volume of 15 mL of cells and solution was 
then centrifuged at 500 x G for 5 minutes.  Meanwhile, the gelatin/fibronectin solution was 
removed from each T25 flask that was previously prepared and 4 mL of supplemented Claycomb 
medium was added to each T25 flask.  The cells were removed from the centrifuge and the 
supernatant was carefully aspirated as to not disturb to cell pellet.  The cell pellet was resuspended 
in 2 mL of supplemented Claycomb medium. Subsequently 1 mL of the cell suspension was 
transferred into each of the two labeled gelatin/fibronectin-coated flasks.  
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 These flasks were then grown to confluency.  Three of the flasks were passaged to T75 
flasks and frozen as passage one (1).  The fourth flask was kept as the working flask and further 
passaged.  It was important to try to freeze a flask or two from each passage in case an issue arose 
with the cells at some point.  This allowed us to return to that earlier, error-free passage.   The 
protocol for passaging to the T75 flasks was largely the same as passaging to the T25 flasks, except 
the volume of supplemented Claycomb medium added after the gelatin/fibronectin was aspirated 
was 9 mL. 
 Generally, the contents of one confluent T75 flask were frozen into 3 cryovials 
(approximately 2.0 x 106 cells/vial).  When cells were needed, one cryovial was thawed into one 
T75 flask.  The T75 flask containing the Hl-1 culture was briefly rinsed with 5 mL of DPBS 
warmed to 37°C and removed by aspiration. Further 3 mL of 0.05% trypsin/EDTA was added into 
the flask and incubated at 37°C for one minute.  The trypsin/EDTA was removed from the flask, 
replaced with 3 mL of fresh 0.05% trypsin/EDTA, and incubated at 37°C for 2 minutes.  After 2 
minutes, the flask was checked under the microscope to ensure that the cells were dislodged.  If 
they were not, the flask was gently perturbed on the benchtop to dislodge any cells that remained 
adhered to the flask surface.  A volume of 3 mL of soybean trypsin inhibitor were added to the 
flask and transferred the 6 mL of solution into a 15 mL centrifuge tube.  The empty flask was then 
rinsed with 5 mL of wash medium, which was aspirated and transferred to the 15 mL centrifuge 
tube containing the cells.  The cells and solution were centrifuged at 500 X G for 5 minutes, then 
removed and the wash medium was aspirated.  The cell pellet was gently resuspended in 4.5 mL 
of freezing medium. A volume of 1.5 mL of resuspended cells were pipetted into labeled cryovials.  
The cryovials containing the cells were placed into a Nalgene freezing jar containing room 
temperature isopropyl alcohol (IPA).  The freezing jar was immediately placed into a -80°C 
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freezer, which allowed the cells to freeze at a rate of -1°C/minute.  Six to twelve hours later, the 
vials were transferred into a liquid nitrogen dewar. 
Maintaining the Cell Culture 
 Cells were fed with supplemented Claycomb medium every weekday. The media was fully 
replaced every day.  T25 flasks received 5 mL of fresh supplemented Claycomb medium daily, 
while T75 flasks received 10 mL of fresh supplemented Claycomb medium daily.  To avoid 
feeding the cells on the weekends, double the supplemented Claycomb medium was added to each 
flask on Friday afternoon.  This medium was fully exchanged on Monday morning. 
 
Figure 19 Schematic of the process for passaging HL-1 cells 
Cell Counting 
 Cell counting is an extremely important part of maintaining a cell bank.  It is pertinent to 
know how many cells are being frozen away in cryovials.  It is also important to keep track of cell 
counts as this is one way to tell if there is a problem with your culture.  When building our cell 
bank, cell counts were also used to determine the doubling time of our cell cultures.  This allowed 
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us to eventually be able to time cell cultures so overnight and weekend passaging would no longer 
be necessary. 
 
Figure 20 Cells being trypsanized to dislodge them from the surface of a flask to which they are adhered.  The red arrow shows a 
layer of cells that have detached from the flask.  The green arrow shows an area of cells which are still attached to the flask 
surface. (Image taken with Keyence BZ-X800 All-in-One Confocal Microscope at 10X magnification) 
 Several methods are available for cell counting.  The most common method is cell counting 
using a hemocytometer.  This protocol is an extremely common practice used in every cell biology 
lab [112].  To use a glass hemocytometer, along with a coverslip, it was cleaned with alcohol 
before use.  The coverslip was then moistened with water and affixed to the hemocytometer.  The 
presence of Newton’s refraction rings under the coverslip indicated proper adhesion.  Typically, 
cells were counted after cells were resuspended after trypsinization and centrifugation. 
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 To count the cells, 100 µL of cells were pipetted into an Eppendorf tube. A volume of 400 
µL of 0.4% Trypan Blue was then pipetted into the same tube and mixed gently, giving a final 
trypan blue concentration of 0.32%.  Using a pipette, 100 µL of the trypan-blue treated cell 
suspension was applied to the hemocytometer.  Both chambers were gently filled under the 
coverslip, which allowed the cell suspension to be drawn out by capillary action.  Using an inverted 
microscope, the grid lines of the hemocytometer were focused on with a 10X objective.  Using a 
hand tally counter, the live, unstained cells (live cells do not up-take trypan blue) in one of 4 sets 
of 16 squares on the corners were counted, as labeled in Figure 21.  When counting, a system 
where cells are only counted when they are within a square or on the right-hand or bottom 
boundary line was used.  The hemocytometer was then moved to the next set of 16 corner squares 
and counting was continued until all four sets of 16 corners were counted. 
 
Figure 21 Hemocytometer chamber:  the four sets of sixteen squares in which cells are counted are labeled 1 to 4.  The densely 
gridded area is not counted. 
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 To calculate the number of live cells per milliliter the average cell count from each of the 
sets of 16 corner squares was taken and multiplied by 10,000.  Then, this number was multiplied 
by 5 to correct for the 1 to 5 dilution from the trypan blue addition.  This final number was the 
number of viable cells per milliliter in the original cell suspension. When splitting an entire 
centrifuge tube into flasks of cryovials, the entire volume of cells and medium needed to be 
considered. 
Cell Doubling Time 
 By maintaining stringent counts of each flask that was passaged while establishing the 
culture in our lab, pinpointing how long it took for the cells to double was determined.  By using 
this information, the timeline for passaging was ascertained. Having this control allowed us to 
avoid passaging over the weekends, as well as at odd times of the night.  It was determined that 
our HL-1 cells double in approximately 2.1 days.  Given the number of cells typically seeded in a 
flask, this means that flasks, whether T25 or T75, are typically ready to be passaged after 
approximately 72 hours. 
Necessity of Determining the Biocompatibility of 3D Printing Resins with HL-1 Cells 
Once the HL-1 cell line was established in the lab, it was necessary to understand the 
limitations of its biocompatibility with non-traditional materials that are often used in our group.  
Specifically, in order to achieve the desired feature sizes to enhance biosensor sensitivity using 
our 3D bioprinter that we developed in house in Chapter 4 it was necessary to develop our own 
printer micro-nozzles, with openings ranging from 500 µm to 100 µm.  To ensure the viability of 
the cells was not further reduced in the printing process, it was necessary to select the proper 3D 
printer resin to print the nozzles.  An extensive study of the biocompatibility of HL-1 cells with 
six 3D printer resins follows.  The results of this study also led to improved fabrication of the 
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culture wells utilized in the packaging of the nanointerdigitated electrodes and plasmonic 
interdigitated electrodes as discussed later in this dissertation. 
Biocompatibility of Blank, Post-Processed and Coated 3D Printed Resin Structures with 
Electrogenic Cells 
The widespread adaptation of 3D printing in the microfluidic and bio-MEMS community 
has been stifled by the lack of investigation into the biocompatibility of commercially available 
printer resins.  By introducing an in-depth post-printing treatment of these resins, their 
biocompatibility can be dramatically improved up to that of a standard cell culture vessel 
(99.99%).  Additionally, encapsulating less biocompatible resins with materials that are common 
constituents in biosensors further enhances the biocompatibility of the material.  This investigation 
provides a clear pathway toward enhancing extrusion bioprinting methodologies and developing 
fully functional and biocompatible biosensor devices especially for interfacing with electrogenic 
cells utilizing benchtop-based microfabrication and post-processing techniques. 
Biocompatibility Testing of 3D Printed Resins 
Conventional micro/nanofabrication techniques allow for the realization of micron- and 
nanoscale features; however, these techniques have several disadvantages, including expensive 
and time-consuming processes when altering the design of a device, difficulty in scaling up from 
prototyping to bulk manufacturing, and 3D geometric design requirements [113-119]. 3D printing, 
also known as additive manufacturing or rapid prototyping, has recently become an important 
technology for revolutionizing biosensor and microfluidic device development because of its 
ability to overcome most of the disadvantages associated with traditional microfabrication 
techniques [113-120]. Unlike traditional microfabrication techniques, 3D printing does not require 




3D printers generally define a three-dimensional object from a computer-aided design 
(CAD) model layer-by-layer in an additive process [117, 119]. The most prevalent types of 3D printing 
utilize polymers, and these types are namely fused deposition modelling (FDM), micro-
stereolithography (µSLA), and digital light processing (DLP). FDM printing involves the extrusion of 
small streams or beads of a material, such as polylactic acid (PLA), that immediately harden to form 
the structural layers of the final device [117, 119]. FDM printing is the easiest to implement and the 
most cost-efficient of these three methods; however, limitations exist in the shapes and feature sizes 
that can be fabricated [117, 119]. Both µSLA and DLP printing produce objects in a layer-by-layer 
fashion via the photopolymerization of a liquid resin. These technologies may also be referred to 
as vat photopolymerization or resin 3D printing [117, 119, 121]. Both µSLA and DLP printing can 
produce highly accurate, isotropic objects with micronscale feature sizes and a smooth surface 
finish. The difference between these two types of printing lies in how the layers are cured. In µSLA 
printing, a laser beam and digital mirrors are used to photocure each portion of every single layer 
of the object, whereas in DLP printing, the entirety of each layer of the object is cured at once 
using a projected display [116, 117, 119, 121, 122]. With respect to the application of these types 
of 3D printed interfaces in biology, especially in the realm of in vitro studies, µSLA and DLP 3D 
printing lend supplemental benefits outside of the ease of microfabrication. Many cell types prefer 
micro/nano textured surfaces, which can be easily achieved by these methods. Such surfaces allow 
cells to better sense and respond to their environment [123-125]. It is important to note that the 
mechanical properties of such commercial resins are not suited for every application in the space 
of biomedical micro-electromechanical systems (BioMEMS) devices, and the choice of 
commercial resins can be motivated by a variety of factors, including the ability to rapidly structure 
microsystems, access to ready-to-use materials and well mechanically characterized materials, as 
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well as cost, consistency, and ease of procurement. If other material properties are desired such as 
conformability, silcones and hydrogels remain as alterative 3D-printable materials potentially of 
interest [126-128]. 
3D printing allows for the accurate and rapid design and fabrication of monolithic devices. 
Although this technology has revolutionized MEMS and microfluidics fields, little investigation 
into the biocompatibility of the most commonly used commercial 3D printing resins has been 
performed to date. This is especially true for electrogenic or electrically active cells (e.g., neurons, 
cardiomyocytes) where no biocompatibility reports have been published as far as our knowledge 
goes [113, 114, 120-122, 129-139]. Many of these “off-the-shelf” 3D printing liquid resins can be 
purchased directly from the individual printer manufacturers, and as a result their compositions 
are proprietary. Thus, the constituent materials, specifically the photoinitiators, surfactants, 
solvents, and shelf-life extending compounds, are unknown. This lack of information is a barrier 
to wider adaptation of 3D printing in the bioelectronic, biosensor, and microfluidic communities, 
as material biocompatibility is of utmost concern for cells interfacing with these materials. Some 
groups have studied some of these resins with little luck in having any extended cell viability, 
except for the few groups that add prolonged UV treatment to the usual post-print processing [100, 
101, 113, 114, 116, 119, 120, 130, 131]. Several of these materials are methacrylate-based as 
deduced from their materials safety data sheets (MSDS) [140-144]; however, their exact 
compositions remain proprietary. Studying these resins in cell culture and improving their 
biocompatibility through post-process treatments is of immense interest to the community and 
provides multiple advantages. First, the ability to design constructs for in vitro biological work 
solely based on 3D-printing microfabrication strategies means that novel and monolithic design 
approaches can be explored. Second, the application of post-processing treatments begins to reveal 
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a larger concept of compound material biocompatibility, by posing the questions of the exact 
material changes occurring during each step. While some effects are readily known and the effects 
of certain treatments can be hypothesized, these steps could allow for the identification of the exact 
components of each resin. 
To test material biocompatibility, a cell type that has been well studied and has predictable 
growth patterns should be used. HL-1 cells are derived from rat atrial cardiac myocytes and are 
the only cardiomyocyte cell line currently available that can continuously divide, spontaneously 
contract, and maintain a differentiated adult cardiac phenotype [100, 101]. Additionally, this cell 
line has been widely characterized using optical, electrophysiological, immunohistochemical, and 
pharmacological methods [100, 101]. 
In this section of this chapter, the feasibility of using resin 3D printing for in vitro biological 
applications by testing the biocompatibility of several commercial resins was explored. By 
utilizing commercially available resins and standard BioMEMS coatings, it was demonstrated how 
several standard processes can be combined to provide enhanced biocompatibility, which in turn 
will create higher accessibility to 3D printed BioMEMS fabrication for the creation of novel, in 
vitro electrogenic assays. With respect to the selection of postprocess treatments for 3D printed 
constructs, the treatments themselves should also be accessible. To that end, coatings that are 
known to enhance biocompatibility and are accessible to all labs, i.e., SU-8 [96, 145], gold [90, 
96, 146], polystyrene [147], Medco/polyethylene terephthalate (PET) [148], and 
polydimethylsiloxane (PDMS) [149] to enhance biocompatibility, were tested for each material. 
With respect to postprocessing surface treatments, we examined isopropyl alcohol (IPA) treatment 
(a common solvent for cleaning freshly printed Methacrylate-based resin parts to remove the 
uncured monomer [150]); ultraviolet (UV) post-curing (a common step to improve 3D printed final 
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structural properties due to enhanced crosslinking, as well as a common sterilization method prior to 
cell culture [121, 151, 152]); thermal baking (a common post-treatment for achieving final, post-print 
properties [121]), and autoclaving (a common sterilization technique [153] that may encourage further 
polymerization due to the high-pressure environment [154-156]). Additionally, several resins were 
tested, as each offers varying mechanical and optical properties, which lends themselves to be 
useful in multiple applications. Indirect and direct characterization of the biocompatibility of these 
resins was then thoroughly characterized. 
3D Printed Chips 
Computer-aided design (CAD) of the sample chips (4 mm x 4 mm x 1 mm) was performed 
in SolidWorks (Dassault Systems, Velizy-Villacoublay, France). The chips were subsequently 
sliced and printed (Figure 22A) using Preform and a desktop Form2 µSLA 3D printer (both from 
FormLabs, Somerville, MA) or Composer and an Asiga MAX UV27 DLP 3D printer (both from 
Asiga, Sydney, Australia) depending on the resin type used.  The Form2 uses a 405 nm laser with 
a 140 µm spot size for curing, while the Asiga uses 385 nm LED light with a pixel size of 27 µm. 
The resins tested for biocompatibility were Clear Resin (FLGPCL04), Flexible Resin 
(FLFLGR02), Dental LT Clear Resin (DLFLCL01), and High Temp Resin (FLHTAM01) from 
FormLabs (Somerville, MA, USA) and the GR-10 Clear from Pro3dure (Iserlohn, Germany). All 
resins tested were printed on the Asiga printer, except for Flexible Resin, which was printed on 
the Form2. 
After printing, the 3D-printed chips were subjected to numerous treatments to increase cell 
viability (Figure 22B). Figure 22B demonstrates the order in which the treatments were performed. 
The post-processing treatment steps ranged from no treatment to a full treatment comprising all 
the different steps, but they were always performed sequentially. The full regimen of the post-
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processing treatments that could be combined is as follows, and the detailed methods are listed as 
the following: sonication rinse in fresh 70% isopropyl alcohol (IPA), ultraviolet light (UV) 
postprint curing, dry thermal postbaking at 80 °C, and full autoclaving cycle at 135 °C. The 
individual variations were performed solely for the FormLabs Clear Resin, to rapidly and 
efficiently idenitfy the major changes in efficacy of post-process treatments to biocompatibility, 
which were then to be applied to all resins. 
 
Figure 22 Resin chip fabrication: a. Schematic of the Asiga Max UV DLP 3D printer and the Form2 SLA 3D printer and 
associated printed resin chips (flexible in black, clear/high temperature in grey and dental in brown). The printer can cure many 
different commercial methacrylate-based photopolymer resins, allowing for a variety of sampling materials, provided the photo-
initiator absorbs between 385-405 nm. Each chip comes printed on a raft and support structure (as shown in the schematic) and 
must be singulated before post-processing. b. Resin chip post-processing stages. Each of the indicated steps and the order was 
the final sequence used for a full regiment of resin treatment. After fully post-processing, the chips can then be assembled in 48-
well plates and sterilized for cell culture. 
IPA-treated chips were washed and sonicated at 40 kHz in fresh 70% IPA (Cole Parmer, 
Vernon Hills, IL, USA) for 15 min in a sonication bath (Fisher Scientific, Hampton, NH, USA). 
UV-cured chips were cured for 6 minutes at 60 °C in the Form Cure UV postcuring station 
(FormLabs, Somerville, MA, USA), which operates at a wavelength of 405 nm. The extended UV 
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treated chip was cured for an additional 30 minutes in the same curing station. Thermally treated 
chips (not shown in Figure 22B) were baked in a benchtop oven (Fisher Scientific, Hampton, MA, 
USA) at 80 °C for 1 hour. Autoclave treated chips were affixed to glass slides (Fisher Scientific, 
Hampton, NH, USA) using biocompatible Kapton® polyimide tape (Dupont, Wilmington, DE, 
USA) and autoclaved in a SterilElite16™ autoclave (Fisher Scientific, Hampton, NH, USA) for a 
two-hour cycle, which comprised one-hour heating followed by an one-hour drying cycle at 135 
°C. Since autoclaving includes a thermal step, resin thermal treatment is not depicted in Figure 
22B. As a measure between the negative controls (listed in the Negative and Positive Controls 
section) and the post-treated resin samples described in the section above, we also prepared resin 
chips that were not cleaned or treated in any way after removal from the 3D printers, aside from 
gently wiping away of any excess uncured resin. 
After the postprinting treatments, some of the chips were coated with materials that are 
prevalent in BioMEMS and microfluidic devices. These coatings included 10 µm thick 
polydimethylsiloxane (PDMS) (Sylgard-184, Dow Corning, Midland, MI, USA) mixed in the 
standard 10:1 polymer to curing agent ratio; 5 µm thick polystyrene (PS, Millipore Sigma, St. 
Louis, MO, USA) mixed into tetrahydrofuran (THF) (Fisher Scientific, Hampton, NH, USA) to 
create a 10% w/v solution; 20 µm thick SU-8 (Gersteltec, Pully, Switzerland); 100 µm thick 
biolaminate layer consisting of a polyethylene terephthalate (PET) film with a single side coated 
with a Medco adhesive (Medco/PET) (Medco Labs, Bedford Heights, OH, USA); and 75 nm thick 
gold (Ted Pella, Redding, CA, USA). Chips with PDMS, PS, and SU-8 were dip-coated and cured 
at 60 °C for 1 hour. Gold coated chips were sputter coated in a Quorum Q150T Sputter Coater 
(Quorum Technologies, Lewes, UK), and the biolaminate sheet was cut to size and applied to the 
chips, with the Medco adhesive acting as the adhesive layer. All thickness measurements were 
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performed using a scanning electron microscope (SEM) (JEOL, JSM-6480, Tokyo, Japan). 
FormLabs Clear Resin chips were coated with each of the afforementioned materials to evaluate 
the effect on biocompatibility as stated earlier, while each of the other resins were only coated with 
PDMS. 
The fabricated and post-processed chips were subsequently adhered to a sterile 48-well cell 
culture plate (Fisher Scientific, Hampton, NH, USA) with biocompatible 353ND epoxy [157] 
(Epotek, Billerica, MA, USA) mixed at a 50:1 epoxy to curing agent ratio for increased 
transparency. The chips were placed in one side of the well (Figure 23A) in order to expose 
sufficient area for the plate reader analysis. The plate was subsequently placed into an oven 
overnight at 45 °C to allow the epoxy to cure. For each experimental set, n = 6 samples were 
prepared. 
The plates were then sterilized, first, by washing each well two times with phosphate 
buffered saline (DPBS) (Gibco, Waltham, MA) for five minutes.  As the next step, the wells were 
washed with 70% ethanol (Fisher Scientific, Hampton, NH) for 10 minutes. The plate was 
subsequently UV sterilized in a biosafety cabinet (NuAire, Plymouth, MN) for 30 minutes and 
then washed with sterile water four times for five minutes each. 
HL-1 Cell Culture for Biocompatibility Testing 
A sterile 48-well plate with the chips affixed was first coated with a fibronectin/gelatin 
(both Millipore Sigma, Burlington, MA) extracellular matrix solution to allow for cell adhesion to 
the surface and incubated at 37°C with 5% CO2 overnight, as previously outlined. The 
fibronectin/gelatin solution is aspirated just prior to cell plating and replaced with 500 µL of 
supplemented Claycomb medium (Millipore Sigma, Burlington, MA). 
59 
 
HL-1 cells were thawed from a cryovial stored in liquid nitrogen and resuspended in 
supplemented Claycomb medium via the protocol mentioned in the Materials and Methods section.  
The cells were then counted using a standard hemocytometer protocol with trypan blue (Gibco, 
Waltham, MA). Typically, each cryogenic vial contains around 1.5 million cells. Since the optimal 
plating density for a 48-well plate is approximately 30,000 cells/well [25], approximately 20 µL 
of the cell suspension was added to each well.  The exact amount depends on the cell density in a 
specific vial and is typically determined at this step in the process. 
 
Figure 23 Luminescence assay: a. Image of 48-well plate with schematic close-up demonstrating the placement and relative size 
of the resin chips in the wells. The grid of green dots represents the sampling points of the luminescence assay. b. Schematic view 
of the luminescence assay process, illustrating the averaged luminescence leading to an output of percent viability. 
Culture plates were incubated at 37°C with 5% CO2 and allowed to reach confluency (3 
days).  Cell culture medium was exchanged daily.  After the cells reached confluency, an ATP 
assay was performed to assess cell viability [158]. Promega CellTiter-Glo (Promega, Madison, 
WI) ATP assay was prepared according to their protocol [158]: 200 µL of supplemented Claycomb 
medium, along with an equal amount of the ATP assay reagent were added to each well, mixed 
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for two minutes to induce lysis, and then incubated at room temperature for ten minutes to stabilize 
the luminescent signal. Luminescence was then recorded for each well using a SpectraMax i3x 
microplate reader (Molecular Devices, San Jose, CA) in a 48-point well scan mode (Figure 23A 
and B). 
HL-1 cells were also optically observed using inverted microscopy (Nikon TS2, Nikon, 
Tokyo, Japan).  Images of the cell growth over time and during beating were procured using a 
camera (Amscope, Irvine, CA).  Live/dead fluorescence images were taken of the cells plated on 
standard microscope slide-sized (25 mm x 75 mm x 1 mm) treated resin pieces adhered to a glass 
microscope slide using 353ND epoxy to make the resin transparent at DIV05 using a Keyence BZ-
X800 All-in-One Confocal Microscope (Tokyo, Japan).  Invitrogen Live/Dead Cell Imaging Kit 
(Carlsbad, CA, USA) was used for fluorescent staining, where live cells fluoresced green (488 nm) 
and dead cells fluoresced red (470 nm). 
Negative and Positive Controls 
To ensure the validity of the experimental protocol, both negative and positive controls 
were designed to clearly demonstrate uninhibited cell death and growth, respectively. For the 
negative controls, 6 mL of each uncured resin was mixed with 24 mL of supplemented media to 
create a 1/4 (v/v) solution. The purpose of this solution was to “leach” the resin into the media, 
leaving potential cytotoxic compounds (which are normally removed during curing and post-
processing steps), in the media. Cells were plated as described in the previous section until adhered 
to the culture well surface (N=6 for each resin), at which time point the leached media was used 
(moving forward) to supplement the cultures. For the positive control, cells were plated until 
adherent as above, and cultured for the duration of each experimental protocol without any resin 
(cured or uncured) present in the wells. 
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Results and Discussion 
The positive and negative controls each serve to highlight the findings of the 
biocompatibility study described in the dissertation. Positive control wells were consistently 
99.99% viable as expected. The negative control wells were nonviable (0% viability) within 12 
hours of the “leached” supplemented media being introduced in culture. This result held for all 
instances of every uncured resin leached media that was used. Uncured resin would most certainly 
never be used in the fabrication of a BioMEMS construct, as uncured resins contain shelf-life 
stabilizers, solvents, monomers, UV-blockers, and photoinitiators [139, 140, 159], and these are 
likely polymerized with the solvent evaporating out of the construct as the 3D structure is cured. 
Again, it is important to note that commercial resins are largely proprietary, so exact chemical 
compositions remain unknown and are an area of interest for future studies. These controls serve 
to demonstrate the necessity of the postcuring steps, including sufficient UV/thermal curing of the 
resin, which would ensure the removal of these overtly cytotoxic compounds [160, 161] that may 
still be present in trace quantities after the initial structural curing of the resin during 3D printing. 
The resins selected were based on both their commercial availability and recommended 
base resins (by the manufacturer) for the respective 3D printing platforms. These resins according 
to the manufacturers are the most used products in BioMEMS, microfluidics, dentistry, artistic 
endeavours, and other fields. As a starting basis for comparison, the various iterations of printed 
materials are deemed biocompatible with HL-1 cells if cell viability exceeded 85.00% [162]. This 
viability marker extends from both the ISO 10993-5 standard and the European Union Reference 
Library European Centre for Validation of Alternative Methods (EURL ECVAM) [162], as well 
as visual observations of cell growth and beating. The percentages shown are based on arbitrary 
luminescence units, corresponding directly to a culture’s population viability (average n = 6). Each 
experimental group was accompanied by a set of positive controls (no resin; n = 6; 99.99% average 
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viability across experiments) that demonstrated the healthy viable nature of the cells used in a 
culture experiment. For each of the resins as mentioned previously, a negative control consisting 
of the uncured resin leached media (n = 6; 00.00% average viability) was performed. 
 
Figure 24 a. Biocompatibility results of incremental improvements in biocompatibility during post-processing for FormLabs 
Clear V4: Clear resin alone showed the lowest survival rate, while washing with IPA resulted in the greatest increase of survival.  
Surprisingly, thermal treatment after IPA washing reduced the biocompatibility slightly even through the result was above the 
accepted values for HL-1 cells.  The combination of IPA + UV + Autoclave resulted in the greatest collective viability.  b. 
Coatings encapsulation of FormLabs High-Temp resin to improve biocompatibility: All samples were washed with IPA, exposed 
to UV for 6 minutes, and subsequently autoclaved. SU-8 and polystyrene had a rather small impact on the biocompatibility. 
Medco/PET and gold resulted in slightly better biocompatibility, and encapsulation in PDMS provided the best results and was 
subsequently used.  c. Biocompatibility of the different resins before and after PDMS coating encapsulation. d. Biocompatibility 
results of the different resins where the chips were only coated with fibronectin/gelatin solution as opposed to the entire culture 
well. 
Experimentally, the FormLabs Clear Resin [140] was tested first (Figure 24A), as it is the 
simplest and most widely available resin accessible for this type of work. All viability numbers 
mentioned in this section are an average of n = 6 samples. Untreated (printed; no wash or post-
processing) FormLabs Clear Resin (FLGPCL04) was first tested as a basis of comparison and 
demonstrated a 43.39% ± 0.70% (mean ± standard deviation for all such numbers from now on) 
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viability. Such a high cytotoxicity was expected because of the presence of the various moities as 
hypothesized earlier [52,53]. Next, the postprocessing treatments were tested in a compound 
manner, beginning with the sonication in fresh 70% IPA, a step routinely recommended to clean a 
resin-based 3D printed structure. The IPA wash alone resulted in a 91.99% ± 0.76% viability, a 
dramatic increase in biocompatibility for this resin. This dramatic increase in viability was 
expected as well, as the IPA rinse removes any uncured resin and other particles that remain on 
the structure after the printing process [42]. Next, an IPA and a UV postcure was tested, resulting 
in a 96.35% ± 0.71% viability. The combination of the IPA rinse and UV curing likely results in 
an increase in viability due to the combination of the removal of uncured resin [42] and further 
crosslinking of the polymer in the UV curing station due to free radical initiated polymerization 
[9,43,44]. IPA and a thermal bake were then tested together resulting in 89.98% ± 0.39% viability, 
prompting a comparison with an IPA and autoclave regimen, which resulted in a viability of 
98.71% ± 0.24%. From this result, it was hypothesized that while the addition of only thermal 
baking enhances the mechanical properties of the resin [9], no further crosslinking is achieved; 
however, the high pressure environment of an autoclave step may in fact further crosslink 
methacrylate-based resins, as previously mentioned in literature [46–48]. The clear benefits from 
combining IPA washing with UV postcuring and IPA with autoclaving prompted the final 
compound postprocessing treatment regimen comprising IPA sonication, UV postcuring, and 
subsequently autoclaving, which resulted in the highest reported HL-1 cell culture viability for this 
type of resin of 99.31% ± 0.17%. 
Although the combined treatments greatly increased the overall viability of the cultures, 
the Clear Resin itself suffered some minor visible damage from the heat and pressure inherent in 
an autoclave step. Due to this, the next resin tested was the FormLabs High Temp Resin 
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(FLHTAM01), which can withstand temperatures of approximately 200 °C [141]. The similar base 
composition of these resins (both being methacrylate-based) [140, 141] allowed for the 
extrapolation of the benefits of the full regiment of post-curing processes used in Clear Resin 
(FLGPCL04). High Temp Resin showed a similar untreated performance viability as Clear Resin 
at 45.26% ± 0.85% and was also able to be converted to be fully biocompatible (meeting the 
established HL-1 biocompatibility metric [162]) with the full postprint treatment regimen and with 
a viability of 87.74% ± 1.6%. Although this resin was significantly less biocompatible after 
treatments than Clear Resin, it was obvious due to the lack of mechanical damage as observed 
using optical microscopy that it qualitatively withstood the autoclaving process far better. 
In order to assess the ability to improve this viability further, several common BioMEMS 
and microfluidics materials coatings that are typically used in conjunction with 3D printing of 
resins in microfabrication were added to the fully postprocessed FormLabs High Temp Resin chips 
(Figure 24B). These coatings served to enhance biocompatibility: SU-8 demonstrated 88.89% ± 
1.0% viability, polystyrene with 89.80% ± 1.2% viability, Medco/PET lamination with 92.31% ± 
2.2% viability, gold with 93.1% ± 1.7% viability, and PDMS with 95.05% ± 0.75% viability. The 
polystyrene coating was found to be porous [163], perhaps causing its lower viability numbers. 
SU-8 was deposited in the same manner, so we suspect that it may be porous as well. The 
Medco/PET lamination had a tendency to be detached from the surface of the chips after extended 
exposure to the culture media, which could have influenced the viability obtained. Gold had 
surprisingly good viability, which is ideal for exposed electrodes on a 3D-printed polymer surface. 
PDMS demonstrated the highest viability of all of the coatings for the FLHTAM01 resin structures, 
which resulted in its subsequent use as a coating for the remaining experiments. 
65 
 
As an additional test for increasing the viability, this resin was subjected to an extended 
30-min UV treatment to assess the possibility of potentially increasing the UV postcure time for 
enhanced crosslinking of dangling polymer chains. The resulting viability of 92.09% ± 0.46% 
(without any material coatings) suggests this is a potential course of action (result not shown in 
Figure 24). The FormLabs Clear Resin, when fully treated and PDMS-coated, did demonstrate a 
99.42% ± 0.11% culture viability, but it still suffered from failures in the structural integrity of the 
material that were induced during the autoclaving cycle. As a result, the usage of High Temp Resin 
is preferred for 3D printed architectures. 
Other 3D-printing resins may additionally be options in the development of novel 
BioMEMS, wearable, and microfluidics devices. In order to enhance the material palette 
FormLabs Dental LT (DLFLCL01) [143], FormLabs Flexible (FLFLGR0) [142], and Pro3dure 
GR-10 resins [144] were additionally tested after being subjected to post-treatment (IPA wash, 6 
min of UV exposure, and autoclave) and material coating (Figure 24C). These resins were selected 
because of their commercial availability, and because they are all designated as biocompatible 
according to ISO standards [122, 129, 130, 132-136, 138, 139, 151, 152, 164-167]. Since PDMS 
showed the best biocompatibility results among all the coatings used with High Temp Resin, it 
was used as the coating in the abbreviated evaluation of these other resins. Surprisingly, the Dental 
LT Resin, reported as a Class IIA long-term biocompatible resin [143], demonstrated a lower 
assessed viability of 85.29% ± 3.4% when compared to the other two resins. Even with the PDMS 
coating, the viability was found to be 89.66% ± 2.8%. Flexible Resin demonstrated 
biocompatibilities of 90.00% ± 1.7% and 93.10% ± 2.7% respectively for post-treatment and 
PDMS-coating, respectively. The drawback for Flexible Resin overall is its opacity, which limits 
its use in in vitro biological research requiring transmitted light microscopy, but this resin could 
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find applications in wearable microfluidics, for instance [168]. Finally, the GR-10 resin 
demonstrated minimal biocompatibility both when fully post-treated (83.33% ± 5.2%) or coated 
with PDMS (85.00% ± 2.9%). Biocompatibility with respect to HL-1 [162] is met with all of these 
conditions with the exception of post-treated GR-10 structures. The reason for this result is 
currently being evaluated. 
Additional testing was performed to demonstrate that the reported results were from the 
resin chips alone and material interactions with HL-1 cells, and not the result of the cells in the 
surrounding well area. Six fully post-treated chips of each of the resins above were adhered to a 
well in a 48-well plate and then carefully coated with gelatin/fibronectin solution so that only the 
chip was coated. Cell viability was subsequently determined using trypan blue exclusion [169]. 
The resulting cell viabilities, shown in Figure 24D, mirror those shown in Figure 24C. 
Surprisingly, the FormLabs Clear Resin and High Temp Resin performed better overall 
than the commercial resins marketed as biocompatible. Obviously, nuanced differences in the 
composition of both resins exist; however, the high temperature resin can meet the viability 
threshold of 85.00% [162] while maintaining its integrity under higher heat and pressure, a 
necessary requirement in microfabrication. The viability of this material can be further improved 
with the addition of coating materials such as PDMS. This material appears to be a promising 
material for BioMEMS, bioelectronics, wearable, and microfluidics researchers. 
HL-1 cells are separated when seeded but grow to form mats (Figure 25A). These mats 
subsequently begin to spontaneously beat, a direct measure of healthy, active cardiomyocyte 
layers. This can be observed optically and can be interpreted as a direct measure of 
biocompatibility since the cells will not grow or beat if their viability is compromised [170]. Cells 
were found to spontaneously beat on all the resins except for the GR-10. Cells grown on the 
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flexible resin were not optically observed due to the opacity of the material. Images of the cell 
growth and matting over the course of the five-day testing period are shown in Figure 25A. 
Expected cell growth and matting was observed for Clear Resin, High Temp Resin, and Dental LT 
Resin; however, the GR-10 resin showed extensive cell death and minimal growth. Live/dead 
fluorescence imaging of the cells on top of the Clear Resin, High Temp Resin, Dental LT Resin, 
and the GR-10 resin was performed using a Keyence BZ-X800 Confocal Microscope (Figure 
25B). Cells on top of the Clear Resin and High Temp Resin showed excellent viability, while those 
on top of the Dental LT Resin and the GR-10 resin showed less desirable viability. This is expected 
from the results presented above. 
 
Figure 25 a. Images of HL-1 cell growth over the course of 5 days. Clear, High Temp, and Dental LT resins all demonstrated the 
expected cell growth and matting. GR-10 resin, however, had extensive cell death with minimal growth. Confluency, or full cell 
coverage of the surface is reached after DIV 5 (five Days in vitro).  After this time, the cells begin to overgrow and die.  b. 
Live/Dead Fluorescence imaging of the HL-1 cells on top of the Clear, High Temp, Dental LT, and GR-10 resins.  The cells show 
excellent viability on both the Clear and High Temp resins, but poor viability on the Dental LT and GR-10 resins.  All scale bars 





Through the establishment of the HL-1 cell line, the NanoBioSensors and Systems 
laboratory now has a bank of several billion cells.  This allows for further passaging of the HL-1 
cell line, as well as an extensive future of cellular testing on a variety of biosensors. 
Biocompatibility testing can easily be performed on new materials on an as needed basis. These 
are being continually performed by the group. 
The expansion of 3D printing into the microfluidic and BioMEMS fields has been 
suppressed by the lack of transparency in the chemical compositions of commercially available 
resins, as well as the minimal amount of biocompatibility data currently available in literature. 
First steps towards establishing biocompatibility of various resins with respect to electrogenic 
cells, utilizing both post-processing treatments and material coatings have been taken. Specifically, 
the results presented here provide a clear pathway toward applying these resins toward 3D 
printing-based 2D and 3D microelectrode array (MEA) devices [145, 163, 171], as well as cell 




CHAPTER 4: EXTRUSION PRINTING OF BIOMATERIALS 
 A portion of the work presented in this chapter has been previously published in IEEE 
JMEMS in 2019 [96]. The “home made” bioprinter work has not yet been published but expected 
to be submitted to IEEE Transducers 2021. 
Introduction 
In recent years, 3D printing has been widely accepted as a viable manufacturing technique 
and has the potential to revolutionize micro/nanomanufacturing and medicine. In the field of 
cellular patterning, 3D printing is known as bioprinting. Using several approaches, biomaterials 
are deposited through a computer-controlled dispensing system in designated areas with high 
accuracy in the micrometer scale [5] [172]. A variety of 3D printing technologies have been 
adapted for bioprinting applications, but the three main techniques that have proven to be most 
suited for bioprinting are inkjet printing, laser-assisted printing, and microextrusion (Figure 26) 
[173-177]. Each of these techniques has advantages and disadvantages. Laser-assisted bioprinting 
is accurate and reliable, but it is suitable only for cell deposition and prone to heating problems 
which can cause cell damage [178-180]. Inkjet bioprinting is the most used bioprinting technique. 
It is inexpensive, easy to set up because it typically involves the modification of off-the-shelf 
printers, easily expandable, high-throughput compatible, digitally controlled, and non-contact; 
however, print heads are prone to clogging, shear forces from printing can lead to cell damage, 
bioink flexibility is limited because bioinks must fall within a specific viscosity and surface tension 
range, and cells are comparable in size to inkjet channels [10, 178, 181-188].  Microextrusion 
bioprinting, which is the focus of this work, has a larger nozzle size which leads to less clogging, 
is capable of printing bioinks with a large range of viscosities and surface tensions, and is the most 
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promising technique for clinical translation; however, it is a higher-pressure printing technique, 
which leads to higher stresses, and thus, a possible decrease in cell viability [173, 189, 190]. 
 
Figure 26 Schematics of the three main bioprinting methods: a. Laser-assisted, b. Inkjet, and c. Microextrusion [191] 
In extrusion bioprinting, material (bioink and cells) is dispensed through a nozzle (or 
syringe) using either pneumatic or mechanical pressure (i.e. plunger, screw, etc.). The nozzle 
moves in the x and z directions, while a stage moves in the y direction. This gives the user complete 
special control of the deposition [192]. Extrusion bioprinting is typically a continuous flow 
process; however, in some cases, discrete spots may be able to be deposited [173, 193]. The larger 
nozzle size of extrusion printers leads to less clogging than in inkjet printing [189]. This means 
that the potential to deposit higher densities of cells exists and that a wider range of bioinks with 
varying viscosities can be used. 
Commercial extrusion bioprinters are exceedingly expensive (upwards of $200,000); thus, 
this technique is often overlooked in laboratory settings despite it being the most promising of the 
three major bioprinting technologies for clinical translation [190]. Most “hobby” 3D printers are 
extrusion printers, and they are extremely inexpensive and relatively open source now that the 
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original patents for this technology (FDM, fused deposition modeling) have expired.  For this 
reason, there is potential for the cost to greatly decrease and implement all the advantages of this 
technique by converting an off-the-shelf printer to a bioprinter, like many have done for inkjet 
printing. 
In addition to the cost and the ability to “Do it Yourself”, extrusion bioprinting has many 
advantages over other techniques.  Extrusion printing allows for greater deposition and printer 
speed, which can facilitate scalability in a timely manner [194].  Extrusion bioprinting can 
accommodate a wide variety of bioinks inks including cell aggregates [195-198], cell-laden 
hydrogels [199-202], micro-carriers [203], and decellularized matrix components [204], while 
other techniques are only capable of printing cell-laden hydrogels.  Additionally, bioprinting at 
high cell densities is currently feasible only using extrusion bioprinting [194].  The extrusion 
bioprinting process is biocompatible with reasonably small process-induced cell damage and 
injury compared to other techniques [192].  Extrusion bioprinting is capable of producing 
anatomically correct porous constructs [205], which is challenging with other methods.  Most 
importantly as mentioned earlier, from an implementation perspective, extrusion bioprinting 
techniques are easy to implement and can be used by those with limited exposure to the technology.   
The major disadvantage of extrusion bioprinting is the limited resolution.  The minimum 
feature size is generally well over 100 µm [206].  This resolution is considerably lower than other 
techniques [207].  Inkjet and laser-based bioprinting can achieve resolutions of 50 μm and 5 μm, 
respectively [208]. 
Notable work on bioprinting using extrusion techniques has been performed by several 
groups. Khalil et.al. spent time working on the extrusion bioprinting of 3D hydrogel scaffolds. In 
this study, rat heart endothelial cells were encapsulated in various hydrogel solutions, including 
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alginate, fibrin, and chitosan, and printed. Their minimum feature sizes were shown to be 250 μm 
[209]. Bertassoni et.al. showed direct-write bioprinting of cell-laden methacrylated gelatin 
hydrogels. This work involved printing HepG2 and NIH3T3 cells suspended in a methacrylated 
gelatin hydrogel using a commercial extrusion bioprinter (NovoGen MMX Bioprinter). They 
showed minimum feature sizes of 500 μm and their hydrogels needed ultraviolet exposure to set 
into defined patterns [210].  
As discussed in the Introduction section, cell printing has been gaining considerable 
traction in the field of biology since the turn of the century. The technology that was first explored 
was inkjet printing technology due to the availability of the technique and its application in the 
printing of conducting and non-conducting polymers [174, 182]. Utilizing this technique cells were 
typically either suspended in a bioink material or printed onto “biopaper” [10, 211-213]. More 
recently, this field has progressed to newer, more cell-friendly techniques that are mostly used to 
create 3D grafts, scaffolds, and cell structures and cellular spheroids in regenerative medicine and 
associated research fields [214]. 
While most current research focuses on 3D cell laden structures, 2D cell printing can be a 
viable technique acting as an alternative to lithographic definition of cells, reducing the number of 
cultured cells and the number of steps required to define these cells in a biosensor device; thus, 
improving the placement of cells, enhancing sensitivity, imaging, and reducing experimental costs 
associated with any cell culture methodology. 
Theoretical Background 
 Shear stress is of primary concern in the bioprinting process [215-217].  Moderate shear 
stress has been shown to influence stem cell differentiation, while excessive shear stress can cause 
cell rupture by disrupting the cell membrane [215, 216].  Excessive shear stresses caused by the 
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small diameter of the printer nozzle, the high speed of printing, and the high viscosity of some 
bioinks are easily generated during the printing process [218].  The level and distribution of shear 
stress in the nozzle itself are directly influenced by the printing parameters including the driving 
force, the printhead structure, and the rheological parameters of the bioink, as shown in Equation 
1, where K is the consistency coefficient, l is the capillary length, n is the consistency index, P is 











𝑛𝑛 �                                                     (1) 
The extrusion bioprinting process can be a useful tool for studying cell injury models in 
vitro, as it is essential to understand how cells respond to process-induced mechanical stresses 
because they alter cell morphology and function [218]. 
 A piezoelectric drop-on-demand printing computational fluid dynamics model simulation, 
as well as some experimental work was developed by Shi et.al. to study the shear stress in nozzles 
during printing [215].  Their experiments specifically examined the effect of the shear stress on 
cell viability and cell proliferation.  Their simulations and experiments demonstrated two results 
that could translate to extrusion printing: (1) the backflow fluid pushed the fluid that entered from 
the inlet down along the wall, which increased the wall shear stress simultaneously, and (2) fluid 
viscosity and nozzle diameter have important effects on the value and breadth of the effect of shear 
stress.  Overall, they found that both cell viability and cell proliferation were decreased with 
increased shear stress.  Individually, shear stress seemed to have a greater impact on cell 




Figure 27 Model from Nair et. al. showing increased shear stress with increased pressure during the printing process.[218] 
Wei Sun and collaborators out of Drexel University in Philadelphia have extensively 
studied extrusion bioprinting and its effects on cell viability, as well as determining optimal 
printing parameters.  Nair et. al. from this group conducted a theoretical study with different 
printing process parameters to analyze and quantify how they impacted cell injury [218].  They 
also aimed to optimize parameters for printing viable cells.   
A phenomenological model that correlated the percentage of live (PL), injured (PI), and 
dead (PD) cells to the process parameters nozzle diameter (x1) and pressure (x2) (Equations 2-4), as 
well as an analytical formulation to predict the cell viability throughout the system as a function 
of the maximum shear stress in the system was developed. 
𝐸𝐸(𝑃𝑃𝐿𝐿) = 0.8563 + 0.655𝑥𝑥1 − 0.0268𝑥𝑥2 + 0.0061𝑥𝑥1𝑥𝑥2 − 0.76𝑥𝑥12 + 0.000352𝑥𝑥22       (2) 
𝐸𝐸(𝑃𝑃𝐼𝐼) = 0.037 − 0.0469𝑥𝑥1 + 0.00297𝑥𝑥2 − 0.002754𝑥𝑥1𝑥𝑥2 − 0.00003488𝑥𝑥12 +
                                                                                                 0.0283𝑥𝑥22                                                 (3) 
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𝐸𝐸(𝑃𝑃𝐷𝐷) = 0.099 − 0.561𝑥𝑥1 − 0.0242𝑥𝑥2 − 0.00496𝑥𝑥1𝑥𝑥2 + 0.665𝑥𝑥12 −
                                                                                              0.000321𝑥𝑥22                                               (4) 
They found that the dispensing pressure had more of an effect on cell viability than the 
nozzle diameter.  The relationship between dispensing pressure and shear stress is shown in Figure 
27.  In another study, Sun’s group tried to determine suitable printing conditions for embryonic 
stem cells to achieve not only high cell viability, but also good printability [219].  Here the 
rheological properties of gelatin/alginate bioinks were evaluated to determine the gelation 
properties under different compositions, printing temperatures, and holding times.  They 
determined that bioinks with longer gelation times resulted in poorer printability.  Their live/dead 
assay showed that cell viability increased with increased printing temperatures and lower gelatin 
concentrations.  Furthermore, they determined that there was an exponential relationship between 
embryonic stem cell viability and the induced shear stress, shown in Figure 28. 
 
Figure 28 Exponential relationship between cell viability and induced shear stress [219] 
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Materials and Methods 
Most extrusion-based cell printing relies on micro-dispensing units (commercial syringe-
based extrusion bioprinters) that are used as designed or with minor alterations to their design. 
Such systems are not suited for depositing inks of different viscosities [220].  Micro-dispensing 
units still typically use conventional pneumatic extrusion processes, which require homogeneous 
bioinks to maintain a constant material flow rate [221].  Altering bioink functionality by 
introducing nanoparticles, cells, or biopolymers may induce inhomogeneities resulting in irregular 
material flow and nozzle clogging [221].  Additionally, they are expensive, with the cost of such 
systems ranging from $15,000 to upwards of $200,000 [222].  This expense makes bioprinting 
capabilities unobtainable for many research groups especially in low resource settings.  Finally, 
micro-dispensing units are not user friendly.  They require specialized training for use. 
Semi-Sterile Rep-Rap 3D FDM Printer Conversion 
The dramatic reduction in implementation costs for bioplotting resulted in the investigation 
of a cost-effective printer through the conversion of an off-the-shelf generic fused deposition 
modeling (FDM) 3D printer (approximately $150, plus $80 in additional parts) to an extrusion 
bioprinter was performed in a semi-sterile environment (Figure 29).   
 
Figure 29 First homemade 3D bioprinter in the NBSS Lab. 
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Some preliminary design and experimental work on the printer development were 
performed by exchange students (Ms. Sandra Springer and Ms. Sarah Fremgen from Hochschule 
Kaiserslautern in Germany) with my guidance (and in collaboration with Dr. Frank Sommerhage, 
part-time Research Associate in our lab) that showed proof of concept results for droplet and cell 
printing. For the cell printing, HL-1 cells from Dr. James Hickman’s lab were printed in a 3% w/v 
gelatin solution at a high concentration (actual concentration was not specified by Ms. Springer).  
Cells remained mostly viable, as shown in Figure 30. The size of the deposited dots was quite large 
(~1mm radius), and the process was performed under non-sterile conditions. Figure 31 shows 3% 
w/v gelatin dots colored with trypan blue for visibility printed with a 30-gauge flat needle.  This 
image allows for better visualization of the relative size of dots printed with this RepRap printer.  
 
Figure 30 HL-1 cells printed with semi-sterile RepRap printer. a. Initial printed spot with radius of approximately 800 µm.  b. 
Cells after 2 DIV.  c. Zoomed in view of cells after 2 DIV. 
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The motion of the original 3D bioprinter was far from smooth, which often resulted in 
inaccurate droplet placement.  Additionally, the large size and number of parts made the possibility 
of moving the printer to a sterile environment nearly impossible.  As Figure 29 shows, the syringe 
pump is also quite sizable.  This led to two specific issues during the printing process.  The first 
issue was that the size and weight of the syringe pump meant that it could not be attached to the 
printer itself. Long tubing needed to be attached to the syringe for printing, which sometimes 
clogged.  The second issue was that the pump often extruded more bioink than intended due to the 
extruder control limitations of the printer. 
 
Figure 31 "Line of dots" produced by the first homemade extrusion bioprinter in the Rajaraman Lab.  The dots had an average 
radius of about 1 mm. 
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Conversion of a Tronxy X1 FDM 3D Printer to a Bioprinter 
The limitations of this first printer led to the purchase of a new FDM printer for conversion 
to a bioprinter.  This new printer needed to be compact yet have a stage large enough to support a 
multiwell plate (128 mm x 85.5 mm x 20 mm) [223].  It also needed to be assembled, so that it 
could be built entirely inside of the biosafety cabinet to ensure sterility.  A Tronxy X1 3D FDM 
Printer, shown in Figure 32, was selected, as it fit all these specifications. 
 
Figure 32 Tronxy X1 3D Printer. 
The Tronxy X1 printer was fully assembled inside of a biosafety cabinet to ensure sterility 
from the onset.  All components of the printer, as well as tools, were heavily sprayed with 70% 
isopropyl alcohol prior to introduction to the biosafety cabinet.  The sterile environment of the 
biosafety cabinet needed to be maintained, as well.  The polymer extruder was not affixed to the 




Figure 33 Syringe pump schematics. a. and b. Final syringe pump body design.  Designed to fit directly onto the extruder plate of 
the Tronxy X1. c. Syringe holder designed to keep the syringe fixed to the syringe pump during printing. d. Syringe insert.  
Designed to fit rubber syringe gasket for improved performance.  The M5 hex nut is glued to the insert to ensure perfectly 
coupled movement. 
 
Custom Syringe Pump Design and Development 
 Measurements of the distance between the screws on the extruder-holder plate fixed to the 
printer arm were taken to design a syringe pump that could be fixed to the printer.  This distance 
was 56.5 mm from center to center.  The syringe pump was designed in SolidWorks and 3D printed 
on the back-converted RepRap FDM 3D printer in 1.75mm polylactic acid plastic in a rectilinear 
pattern with a 25% infill density at 35 mm/s with an extruder temperature of 200°C and a bed 
temperature of 60°C.  The syringe pump was comprised of three parts: (1) the body (Figure 33A 
and B), (2) the syringe holder designed to keep the syringe fixed to the syringe pump during 
printing (Figure 33C), and (3) the syringe insert (Figure 33D).  
Printer Micro-Nozzle Design and Fabrication 
 Cells were printed using 30-gauge dispensing needles, as well as 3D printed nozzles.  The 
3D printed micro-nozzles were designed with a flared output to reduce the physical stress on the 
cells [224], thus, decreasing the likelihood of cell death in the nozzle itself.  The 3D printed nozzles 
were designed in SolidWorks.  Outer nozzle dimensions were height of 16.4 mm and width of 6.25 
mm at the top and 250 µm at the bottom.  The inner nozzle dimensions are 4.25 mm top opening 
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with a height of 6.4 mm, followed by a tapered cone area with a height of 5 mm, followed by a 1 
mm height by 100 µm cylinder, and finally another cone leading to the opening that starts with a 
width of 100 µm and ends with 250 µm opening and is 500 µm mm in height. This design is then 
printed on the Asiga DLP 3D Printer in High Temperature (FLAMHT01) resin from FormLabs 
(Somerville, MA).  After printing, the nozzles were subjected to the post-print treatment described 
in Chapter 3 to increase biocompatibility.  This treatment includes a six-minute wash in fresh IPA 
followed by a six-minute UV treatment followed by autoclaving.  The micro-nozzle opening is 
rinsed with a syringe of IPA before and after each step to ensure that the opening is clear of any 
residual uncured resin. 
Results and Discussion 
The Tronxy X1 3D printer was successful assembled inside of the biosafety cabinet (Figure 
34); thus, making it sterile.  After several iterations fixing some design flaws such as no room for 
screws on the pump body, blocked screw holes, and realizing that the syringe pump body size 
could be reduced, a successful print of the syringe pump was produced and subsequently installed 
on the 3D printer.  A small screwdriver is needed to attach and detach the syringe holder before 
and after each use.  This is also kept inside of the biosafety cabinet to maintain sterility. 
Initial testing of the converted 3D printer required many test prints.  While the focus 
remained on dots due to the nature of the sensor design and cell coupling to microsensors in our 
laboratory, several other patterns were explored.  These patterns can be seen in Figure 35.  During 
this phase of test, it was found that blanket coating of the plating surface with fibronectin to 
encourage cells to adhere to the surface caused full surface wetting upon droplet impact due to the 
hydrophilic nature of both the petri dish and the fibronectin [225]. 
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Micro-nozzles made of high temperature resin were successfully printed and post-treated 
using the pre-determined steps in Chapter 3.  The nozzles were designed to have 250 µm channel 
before the flared opening, as shown in Figure 36A.  The actual results of the print are observed in 
Figure 36B.  Due to the feature size limitations of the Asiga 3D printer, as well as the physical 
changes that occur in the resin during the post-print treatments, it was expected that the actual 
channel would translate to be less wide.  The opening width was found to be 150 µm ± 11.42 µm 
(N=3) in the SEM image (Figure 36C), which is a deviation of 100 µm from the design dimensions.  
Additionally, the flared opening did not print at all.  Instead, the opening is a single channel that 
averaged 150 µm wide.  The channel prior to the flared opening was designed to be 100 µm, so 
there was a deviation of 50 µm from the design here.  The remainder of the micro-nozzle 
dimensions printed as designed.  Table 5 shows the full micronozzle dimensions. 





Figure 34 Fully converted Tronxy X1 3D printer.  Left: wide view showing the entire set-up including the control box, stage, and 




Figure 35 Cells were printed in a variety of patterns. Initially, the petri dishes were grossly coated with fibronectin. This resulted 
in full surface wetting due to the hydrophilic nature of both the petri dish and the fibronectin. To achieve the desired patterns, it 
was necessary to print the coating, as well. Printed patterns include dots, lines, and an s-shape. 
 
Figure 36 3D printed nozzle. a. SolidWorks schematic showing the intended design of the nozzle. b. SEM of the full nozzle.  Scale 




Figure 37 Comparison of sizes between spots that were hand plated, printed using a hypodermic needle, and printed using the 
3D printed micronozzle.  The 3D printed micronozzle provides the smallest spot sizes. 
  To demonstrate the effectiveness of the 3D printed micro-nozzles, it was necessary to 
ensure that the radius of printed spots was reduced.  A detailed experiment was carried out to 
accomplish this task encompassing hand plating, hypodermic needle-based bioprinting and micro-
nozzle-based bioprinting. Each group was plated in a separate 6-well plate for five days.  Media 
was changed daily, and cells were imaged daily.  Cell growth was monitored over the course of 
these five days, and a live/dead assay was performed on the fifth day to assess the viability of the 
HL-1 cells through confluency for each condition.  The results followed the expected trends very 
well over the full assay of five days (Figure 37).  The hand plated spots were consistently the 
largest.  They had a radius of 2,192 µm ± 111 µm when initially plated and grew as expected over 
the course of the five days.  The radius of the hand plated spots grew by 523 µm ± 81 µm over the 
course of five days.  The spots printed with the hypodermic needle were the “intermediate” sized 
spots, with their average radius being approximately 1,351 µm ± 105 µm when printed and grew 
86 
 
as expected over the course of the five days.  The radius of the spots printed with the hypodermic 
needle grew by 470 µm ± 56 µm.  Finally, the spots printed with the 3D printed nozzle were the 
smallest of the three with their radius being approximately 775 µm ± 49 µm when initially printed.  
They also grew as expected over the course of the five days.  The radius of the spots printed with 
the 3D printed nozzles grew by 188 µm ± 24 µm over the course of the five days.  All three 
bioprinting conditions demonstrated excellent viability (Figure 38).  
 
Figure 38 Live/Dead confocal images of the three plating conditions.  Left: hand plated.  Middle: printed using a hypodermic 
needle.  Right: printed using the 3D printed nozzle.  All three conditions showed similar viability, meaning that the printing 
process had little effect on the cells. All scale bars are 500 µm. 
Precision Cell Plating via Micro-Dispenser Device on an MEA 
As presented above, extrusion printed spots of sizes down to approximately 775 µm with 
the 3D printed printer micro-nozzles were achieved.  These nozzles also demonstrated extremely 
good viability, as compared with both hand plating and cells printed with hypodermic needles as 
nozzles.  By applying theoretical understanding of how shear stress impacts cell viability and 
optimizing printing speed, hydrogel viscosity, and micro-nozzle diameter, we were able to design 
our printer and adjust its parameters to minimize this shear stress, and thus increase cell viability.  
While these results are an improvement over other such 2D extrusion printing with cell-laden 
hydrogels, the resolution is still not low enough to allow for ideal cell-electrode coupling in devices 
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such as microelectrode arrays (MEAs) with individual electrodes sized at 30 µm and a pitch of 
200 µm. While HL-1 cells are great for demonstration and materials testing purposes, the tissue 
chips community is moving rapidly toward human cells. These electrogenic cells, such as hiPSC-
CMs and human motoneurons require vastly improved coupling methods with underlying 
analytical tools such as microelectrodes. Additionally, a typical HL-1 cell assay is 5 days in vitro, 
while most disease states and organ-chips need to be maintained and monitored a lot longer 
(months rather than days). 
In this part of the chapter, droplets of media containing a small number of cells were placed 
onto protein-coated surfaces using a micro-dispenser device. This research was performed as a 
collaboration; thus, our cell printer was not used here due to its limited resolution.  This approach 
introduces a method of precise, non-lithographic patterning of cells (more specifically electrogenic 
cells, human motoneurons and human cardiomyocytes provided by Prof. James Hickman) on 
precision nanomaterial enhanced microelectrodes (developed by my colleague in the group, Ms. 
Nilab Azim) to increase the probability of cell-electrode coupling, while reducing inaccuracies and 
expenses typically associated with cell plating [226]. The precision plating of cells using a micro-
dispenser device was performed in collaboration with Dr. Frank Sommerhage and Prof. James 
Hickman’s group at the NanoScience Technology Center in UCF. 
Materials and Methods 
Human electrogenic cells were cultured as described earlier [227]. In brief, human 
motoneurons (Neural Stem, Rockville, MD, USA) and human induced pluripotent stem cells 
(iPSCs) differentiated into cardiomyocytes (Cellular Dynamics International, Madison, WI, USA) 
were thawed and subsequently plated in a 60mm petri dish coated with 1 mL of laminin (Sigma 
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Aldrich, St. Louis, MO, USA) solution for motoneurons or 1 mL of fibronectin (Sigma Aldrich, 
St. Louis, MO, USA) for cardiomyocytes three to four days prior to the precision plating step. 
Precision plating of the cells on an 8 x 8 Microelectrode Array with precision enhanced 
nano-porous platinum microelectrode coating (developed by my colleague Ms. Nilab Azim and 
the subject of an accepted paper [163]) was performed using a modified regenHU 3D Discovery 
Fluid Dispenser (regenHU Ltd., Villaz-St-Pierre, Switzerland) in a semi-sterile environment. The 
programs which controlled the plating patterns were designed with BioCAD (regenHU Ltd., 
Villaz-St-Pierre, Switzerland) or simple GCode. Cells were transferred into dispenser syringes at 
densities between 5 x 106 and 6 x 106 cells/mL (standard for both cell types). After precision 
plating, the surfaces were placed into an incubator for 20 to 30 minutes to allow the cells to adhere. 
For both motoneurons and cardiomyocytes, media with an antimicrobial (streptomycin) and an 
antibiotic (penicillin) was used. 
Chemical and electrical stimulation, as well as daily spontaneous recordings, of the 
precision plated cells were performed to determine the specificity of precision plating. Chemical 
stimulation of cardiomyocytes was performed by adding norepinephrine (Sigma Aldrich, St. 
Louis, MO, USA) to the culture well in concentrations from 0 μM to 128 μM. Chemical stimulation 
of motoneurons was performed by adding glutamate (Sigma Aldrich, St. Louis, MO, USA) to the 
culture wells at concentrations from 0 mM to 4 mM. The electrophysiological activity of the cells 
was measured by interfacing the MEAs with the Axion MUSE system and AxIS software (Axion 
BioSystems, Atlanta, GA, USA). Cells were allowed to stabilize for five minutes, and then cellular 
activity was recorded for three minutes before and after each chemical stimulation step. 
Human motoneurons were electrically stimulated using a biphasic pulse (-500 mV for 50 
ms followed by 500 mV for 50 ms) in the Axion BioSystems AxIS software. Cells were allowed 
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to stabilize for five minutes prior to the experiment. Electrodes were selected for electrical 
stimulation based on the strong signal amplitudes (>5 μV) exhibited by the cells. The selected 
electrodes were stimulated within a three-minute recording window. This stimulation process was 
repeated three times and the data was analyzed and averaged. 
Results and Discussion 
Cellular electrophysiological activity of human motoneurons was measured regularly after 
approximately 14 days in vitro (DIV). The precision plated motoneurons produced a classic action 
potential with highlighted average, as shown in Figure 39, and demonstrated increased spike 
activity throughout their lifetime (Figure 40) [228]. Such classic action potential sequences were 
measured across several microelectrodes proving precision plating through micro-dispenser is as 
effective as normal hand plating. The cell cultures were maintained and showed successful spike 
activity for more than two months in culture (Figure 40). 
 
Figure 39 Example of a clearly repeating action potential for precision plated motoneurons recorded at DIV32 depicting a 




Figure 40 The cell cultures were successfully maintained in an in vitro setting for more than two months. The increased spike 
activity with error bars and the range of the precision plated cultures is demonstrated for their lifetime. 
On the electrodes that were not precision plated, no neuronal activity was seen. This result 
demonstrates the power of the precision plating technique and the specificity to which human 
motoneurons can be coupled on specific electrodes. In addition to recording, the stimulation 
response data was post-processed using MATLAB and plotted in Origin, to show the specificity 
of the stimulation. Additionally, specific electrodes were electrically stimulated, eliciting a 
response on the stimulated electrodes with no elicited activity on the rest of the device, as shown 
in Figure 41. Other researchers such as Wagenaar et. al. showed similar stimulation results with 




Figure 41 The stimulated electrode (85) elicited a response from the cells that were precision plated on it. The control electrodes 
(3 neighboring channels, 75, 76, and 86) showed some stimulation crosstalk, but the elicited response did not affect the 
neighboring channels, nor was there any response elicited in these channels. 
 
Figure 42 The mean spike count of precision plated human motoneurons chemically stimulated with glutamate is depicted as the 
normalized data from three active electrodes. The spike activity increases with increased concentrations of glutamate with peak 
activity observed at 1 mM. This is followed by a sharp decrease in spiking to zero, known as hormesis. 
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Chemical stimulation of motoneurons with glutamate showed a dose-dependent increase 
in spike activity peaking at about 1 mM (Figure 42). The observed activity dropped to 0 Hz when 
4 mM of glutamate was added to the culture well. This follows the work of Jiang et. al., which 
showed that low levels of activation of receptors by glutamate engages the stress response 
pathways of the neurons, but excessive activation of the receptors by glutamate kills the nerve cells 
because of excitotoxicity [230]. 
Precision plating successfully allowed the human motoneurons to have localized growth 
on specific electrodes, while preserving their expected electrophysiological behavior during 
culture, as well as during stimulation. The electrical stimulation of specific electrodes was possible 
with minimal to no interference from surrounding electrodes and minimal stimulation effects on 
these electrodes. Precision plating offers a convenient method to yield significant results from 
small populations of motoneurons cultured in synaptic isolation on the same device. 
For human cardiomyocytes, cellular activity was measured on a regular basis starting after 
2DIV. The precision plated samples showed a classic cardiac signal with uniform beat periods, 
which varied from channel to channel due to the isolated populations. No signal was detected from 
electrodes that were not precision plated. Cardiomyocyte chemical stimulation depicted a steady 
decrease in cardiac action potential length with increasing concentrations of nor-epinephrine 
(Figure 43). Figure 43 also shows that the frequency (in beats per minute) increased with increasing 
concentrations of nor-epinephrine. The observed IC50 (concentration of an inhibitor where the 
response is reduced by half) of approximately 5 μM agrees with values reported in literature as 





Figure 43 Cardiac dosing data – Top: Beat period reduction with varying concentrations. The beat period decreases with 
increasing concentrations of nor-epinephrine; Bottom: Beats per minute increase with increasing concentrations of nor-
epinephrine in agreement with literature. 
Precision plating allowed for small populations of cells to be placed precisely on and 
around a specific electrode, or a group of electrodes, as opposed to classic techniques, such as hand 
plating where cells tend to cover the entire surface area. As a result, precision plating is cost 
effective compared to standard plating, which becomes significant in the case of expensive human 
stem cells. The developed method becomes advantageous when optimizing for applications such 
as personalized medicine where the number of cells that can be isolated from a diseased patient is 
going to be limited and as a result maximal efficacy of plating of these cells is required. Figure 44 




of electrodes, respectively. The “dot” pattern is intended to specifically cover one electrode with 
cells and was the focus of this study; however, the “semi-circle” pattern demonstrates the 
flexibility of this plating technique for future applications. Optically monitoring the “dot” pattern 
on a device over time shows the change, or blurring, of the pattern for up to 30DIV. The precision 
plated populations of motoneurons remained in nearly the same area for approximately 30 days, 
as shown in Figure 45; however, an increased spot-size from approximately 150 μm to 360 μm in 
diameter (N=3) indicated that the cells remained mobile and blurred the initial dot size. This 
indicated the growth and survival of a healthy human motoneuron culture throughout the lifetime 
of the cells. 
 
Figure 44 Hand plating versus precision plating of human motoneurons – a. Cells hand plated on a device show a confluent 
layer of cells. The cells are randomly distributed on the grid of microelectrodes; b. Cells precision plated in a spot right on top of 





Figure 45 Tracking of a precision plated spot of human motoneurons over time. The spot size increased over time, which shows 
that the culture was healthy and growing. This observation held for N=3 experiments for approximately 30 days. 
Summary 
Classic cell plating techniques are useful when an overall picture of electrogenic cellular 
activity is required for cells that are available aplenty. This precision plating technique developed 
here allows for an order of magnitude or more improved coupling with electrodes, passive 
recording responses for a long time (in excess of 2 months) as well as the study of electrical or 
chemical stimulation responses of small populations of cells (valuable cells such as human cells 
that are difficult to attain) on specific electrodes, or groups of electrodes.  While the converted 
micro-dispenser used here was extremely effective and could selectively couple on to 30 µm 
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microelectrodes that are spaced 200 µm apart, the converted Tronxy X1 3D printer provides an 
excellent “do-it-yourself” solution for cell printing.  Although the printing resolution is still limited 
to approximately 775 µm, it still provides better cell-electrode coupling than grossly plating a 
biosensor device in addition to improving specificity and reducing costs of cell culture. This 
resolution can be improved with higher resolution micro-nozzles. Moving forward such a 





CHAPTER 5: CELL-BASED BIOSENSOR PLATFORMS – nIDEs AND 
pIDEs 
Adverse cardiac events are a major cause of late-stage drug development withdrawals. 
Improved in vitro systems for predicting cardiotoxicity are of great interest to prevent these events, 
improve heart-on-a-chip models, provide greater experimental control, improve specificity, and to 
reduce costs involved in the introduction of cardiac drugs into the marketplace. Additionally, 
retinal pigment epithelial cells serve as regulators in the eye.  Through the expression and activity 
of specific proteins, this cell layer oversees the transport of nutrients and waste to and from the 
retina [232, 233].  The ability of the retinal pigment epithelium to properly express and activate 
these specific proteins becomes compromised with age and with other conditions that cause 
toxicity.  This can lead to blindness.  Such diseases of interest are Age-Related Macular 
Degeneration and Diabetic Retinopathy.  Improved in vitro systems for studying the relationship 
between blindness and the retinal pigment epithelium is of great interest to many researchers.   
Interdigitated electrodes (IDEs) affixed with a culture well provide a simple, suitable 
solution for in vitro analysis of cells because of their high sensitivity, ease of fabrication, and label-
free, nondestructive analysis. Culturing cardiomyocytes onto these IDEs allows for the use of the 
IDE–cell combination in predictive toxicity assays. IDEs with smaller interdigitated distances 
allow for greater sensitivity, but typically require cleanroom fabrication. Here the definition of a 
simple IDE geometry on a printed nanostructured substrate, demonstrate a Cellular Index (CI) 
increase when compared to an IDE on a planar substrate is reported. The nanostructuring results 
in an increased sensitivity of each electrode gap width investigated. An additional measurement 
modality may be introduced for the first time to our knowledge through plasmonic resonance 
enhancement, thus a plasmonic interdigitated electrode (pIDE). The entire nanostructured IDE 
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(nIDE) is fabricated and assembled in a rapid nanofabrication environment; thus, allowing for 
iterative design changes and robust fabrication of devices. Both impedimetric and plasmonic 
modalities are combined and demonstrated together. Further sensitivities from individual sensing 
modalities have been isolated and studied separately.  
Hypotheses and Publications 
 Several hypotheses are being evaluated in this chapter.  The  first hypothesis was that the 
interaction of the nanostructured PAN substrate with the electrodes should increase the sensitivity 
of the IDEs, and as a result, electrodes with a larger pitch should have the same performance as 
electrodes that are orders of magnitude smaller on standard, planar substrates. The second 
hypothesis was that the nanostructured PAN substrate layer can exhibit surface plasmon resonance.  
Finally, the third hypothesis evaluated was that through careful experimental design the individual 
contributions of each mode to the sensitivity enhancement can be determined: geometric, 
nanostructured surface, and plasmonic. In summary, through the combination of fabrication and 
measurement techniques the sensitivity of interdigitated electrode-based biosensors can be 
dramatically enhanced by several orders of magnitude.  
 Some of the work in this chapter has been previously published in Biosensors in 2018 [90] 
and IEEE JMEMS in 2020 [146], and will be presented at the 30th Anniversary World Congress 
on Biosensors in Busan, South Korea in July 2021. 
Introduction 
Drug-induced cardiotoxicity accounts for one-third of safety-based withdrawn 
pharmaceuticals, making it the number one cause of drug withdrawal, limitation, and development 
termination [14-16]. As of 2016, the Tufts Center for the Study of Drug Development estimates 
the cost of developing a new drug is on an average 2.89 billion US dollars [234]. Because of this 
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high cost, improved in vitro systems for predicting drug-induced toxicity are of great demand in 
the pharmaceutical industry to decrease late-stage drug attrition, advance rapid development, and 
reduce monetary loss [15, 16]. 
Interdigitated electrodes (IDEs), which are generally comprised of two individually 
addressable, interwoven, comb-like electrode structures, are one of the most favorable and widely 
used transducers as chemical and biological sensors because of their low cost, high sensitivity, and 
ease of fabrication [12]. By affixing a culture well to the IDE substrate, a biosensor can be easily 
fabricated. This allows for cells to be cultured onto the surface and assessed with label-free 
electrical and optical assays. A low-voltage signal induces a current between the IDEs. The cells 
on the electrodes at the bottom of the culture well impede this current, and a change in impedance 
results [14]. Measuring this impedance change across these electrodes gives an indirect measure 
of the number of cells in each culture well, as well as an assessment of the interaction between the 
cells and electrodes [15]. Cellular impedance measurements are useful for studying cell growth 
and drug interactions in vitro without the use of destructive labelling procedures with fluorescent, 
chemiluminescent, or radioactive chemicals [235]. Recently, these efforts are gaining industrial 
acceptance with efforts of collaboration between various electrode manufacturers to introduce 
rapid assays with uniform standards across industrial and academic testing laboratories for testing 
cardiotoxicity [236]. 
Electrochemical impedance spectroscopy (EIS) can be combined with surface plasmon 
resonance (SPR), as they are two of the most widely applied label-free monitoring methodologies 
for cell-based biosensors [90, 237]. They are both non-invasive and allow for continuous 
monitoring of cells over a long time; however, they are each based on different physical principles 
and provide different types of information about the cells [237]. A combination of EIS and SPR 
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measurements could provide a powerful means to monitor cells that overcomes the molecular 
specificity of each of the individual techniques. Such measurements are useful in monitoring cell 
growth, studying drug interactions, toxicity, safety, etc. all in a label-free fashion [12].  
A nanoscale biosensor with thin, gold IDEs on a nanohole array substrate with dual-sensing 
capabilities has been realized. SPR is induced by illuminating the surface with light having a 
wavelength equivalent to the plasmonic resonance peak [238]. Exciting the surface plasmons while 
measuring the impedance of the biosensor simultaneously results in increased device sensitivity. 
These two simultaneous modes are further subdivided into geometric, surface conditioning, 
plasmonic and other considerations.  
Predictive toxicity assays on IDEs based on human pluripotent stem cells may aid in 
predicting potential safety issues of drug candidates early in its development process, provide 
information about the mechanisms of drug-induced organ toxicity, reduce the reliance on animal 
testing, and increase the relevance of preclinical safety tests [15, 16, 236]. Human induced 
pluripotent stem cell (iPSC) differentiated cardiomyocytes are the ideal candidate for 
cardiotoxicity cell-based studies. They exhibit the molecular and functional properties of an intact 
human heart, and their electrical signatures can be monitored using non-destructive impedance 
sampling [15]. 
Several IDE and impedance-based biosensors exist, but many of them require the use of 
expensive commercial systems [13-20, 239] for data analysis and involve cost prohibitive 
cleanroom-based fabrication approaches for the IDE micro and nanostructuring [21]. These 
systems use densely packed electrodes, which cover much of the substrate surface and prohibit 
optical tracking of cells. Other approaches integrate microelectrode arrays with IDEs, which 
101 
 
allows for more comprehensive measurement at the cost of more complex fabrication processes 
[15]. 
Bioimpedance sensors offer an inexpensive, label-free solution for MEMS-based medical 
diagnostics and cell tissue research. Typically, interdigitated electrodes (IDE) are used where high 
sensitivity and high selectivity are desired. The output sensitivity and selectivity of an IDE is 
controlled through careful design of the active area, width, and spacing of the electrodes. Improved 
sensor impedance is achieved when the electrode spacing is comparable to the length of the 
biomolecule of interest (typically 1 nm to 100 nm) [11, 178, 240]. In addition, the concentration, 
growth, and alteration of the physiological state of cells during cultivation can be detected as 
impedance changes [241]. 
One of the goals for cell-based bioimpedance studies is to maximize the device sensitivity. 
“Circle-on-line” electrode array geometries are one way to improve the signal strength via greater 
electrode surface area, thus increasing sensitivity. Another way is through decreased electrode 
gaps. Most IDE biosensor studies have demonstrated a micron scale electrode gaps (minimum of 
5 µm) [2, 3, 21, 92, 241-243]; however, some groups have demonstrated sub-micron electrode 
gaps (300 nm or 500 nm) fabricated through wet etching and hot embossing lithography (typically) 





Figure 46 a. Indium tin oxide IDE on glass substrate fabricated via laser micromachining by Tandon et. al.  Electrodes are 200 
µm with 200 µm gaps.  Scale bar is 200 µm. b. Screen printed silver/silver chloride IDE biosensors fabricated on a glass slide by 
Mansor et. al.  Electrodes are 400 µm wide with gap widths of 300 µm, 400 µm, and 500 µm. c. Zinc oxide IDE on silicon 
substrates fabricated using conventional photolithography and etching techniques by Tasakaren et.al.  Electrodes are 
approximately 200 µm apart and 16 µm wide. 
 Bioimpedance sensors are an active commercial area of research, as well. Several 
commercial systems for impedance-based biosensors exist; however, the cost is typically high, and 
the main one requires specific form factors for devices. ACEA Biosciences [248] produces several 
IDE-based systems (Figure 47) with “circle-on-line” electrodes of varying electrode gap widths 
from 10 µm to 100 nm. Their system is essentially a form-specific impedance sensor with a special 
software that converts impedance measurements to other useful metrics (cell index, beat period, 
etc.). Their system is label-free, has high sensitivity, and allows for cells to be followed in real 
time; however, the culture plates are not reusable, have transparency issues, are restricted to a fixed 
form factor and are expensive. The approximate cost of their basic system is $200,000 with the 
microsensor plates (Figure 47) costing $70 or more each, depending on the electrode gap width 




Figure 47 Top: One of ACEA Biosciences current systems.  This system is designed specifically for cardiac cells and is featured 
in many of the cited papers within this chapter. Bottom: An example of one of the specially designed well plates required for 
using ACEA’s systems. 
Here a new impedance-based sensor that allows for long term in vitro cellular analysis with 
high fidelity is presented. IDEs are placed atop a nanostructured polyacrylonitrile (PAN) substrate, 
whose geometry is designed to maximize the interaction with the electrodes and cells. As a result, 
the device is fashioned as nanostructured Interdigitated Electrodes (nIDEs). Both the IDE and the 
nanostructured PAN substrate are fabricated utilizing the “Rapid Micro/Nanofabrication 
Approaches” presented in the previous chapters in this dissertation.  This results in cost 
effectiveness, rapid translation from design to a fabricated device, utilization of direct write 
techniques, and the ability to reduce drug candidate testing times by an order of magnitude or more 
with dramatically increased sensitivity despite coarser geometries.  
Theoretical Background 




Figure 48 Simplified Randles circuit. 
Impedance Theory 
Impedance is the opposition of the flow of alternating current in a complex system when a 
voltage is applied.  Impedance is essentially the representation of resistance in an AC system.  
Instead of just having a magnitude, it becomes complex and is comprised of both a magnitude and 
a phase, i.e. real and imaginary parts [239].  In biosensor research, we measure impedance by using 
electrochemical impedance spectroscopy (EIS).  EIS allows for the study of the interface between 
an electrode and an electrolyte, which is typically cellular medium in the case of this type of 
research. 
The simplest, but also most reasonable representation of EIS for the applications presented 
within this dissertation, is the simplified Randles’ equivalent circuit [249-251].  This circuit, 
pictured in Figure 48, is comprised of three components: (1) a solution resistance (Rs), (2) a charge 
transfer resistance (Rct), and (3) a double-layer capacitance (Rdl).  The solution resistance is simply 
the resistance of the electrolyte.  The charge transfer resistance is the resistance against the process 
of electron transfer from one phase to another, in this case between the electrode and electrolyte.  
Finally, the double-layer capacitance refers to the polarization of ionic charge at the surface of 
electrodes in EIS systems.  The capacitance here is directly related to the electrode surface area 
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and the size of the ions.  The double-layer capacitance increases with increased electrode surface 
area.  The complex impedance of a simplified Randles’ circuit is given in Equation 1 [249].   
𝑍𝑍(𝜔𝜔) = 𝑅𝑅𝑠𝑠 +
𝑅𝑅𝑐𝑐𝑐𝑐
1+𝑅𝑅𝑐𝑐𝑐𝑐𝐶𝐶𝑑𝑑𝑑𝑑𝑖𝑖𝑖𝑖
                                                       (1) 
The complex impedance can be further separated into its real and imaginary parts given by 
Equation 2 and Equation 3, respectively [249]. 
𝑍𝑍𝑅𝑅𝑅𝑅 = 𝑅𝑅𝑠𝑠 +
𝑅𝑅𝑐𝑐𝑐𝑐
1+𝑖𝑖2𝑅𝑅𝑐𝑐𝑐𝑐2 𝐶𝐶𝑑𝑑𝑑𝑑




2                                                             (3) 
When cells are cultured on the IDEs, they are added to culture dishes in suspension.  At 
this point, the cells are spherical in shape.  As the cells begin to reach the substrate, attachment 
sites begin to form, and the cells gradually transform from spherical to a flattened shape and the 
morphology becomes “spread out”.  This process generally takes two to four hours for most 
cultured cells [251].  The individual cells maintain this morphology until they divide, at which 
time they once again become rounded, furrow, and divide forming two cells.  These two cells, 
termed daughter cells, spread out until another division occurs and the process continues. All these 
processes impact the double layer capacitance of the IDEs and hence changes to the impedance 
are observed. 
Plasmonic Theory 
Plasmonics is comprised of the science and applications of noble metal structures that can 
guide and manipulate visible light at the nanoscale.  The optical properties of metals are partially 
determined by the resonant interaction between light and their surface free electrons at a metal-
dielectric interface [252].  These longitudinal surface change density waves of conduction 
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electrons coupled to light are called surface plasmon polaritons (SPPs).  To excite SPPs on a 
surface using light, additional momentum must be provided either by patterning a grating structure 
on the film or by evanescent coupling of light into the metal.  Resonant excitations of these optical 
fields, also called surface plasmon resonances (SPRs), are sensitive to the dielectric materials that 
are in contact with the metallic surface [253].  SPRs in the visible/ near-infrared wavelength range 
are of interest because there is favorable optical confinement at these wavelengths [253]. 
Nanohole arrays exhibit peculiar and complex optical properties due to the presence of 
both localized and propagating plasmons, as well as their interacting effects [254].  The extinction 
spectrum of nanoholes in thin films contains one peak, called a transmission minimum, that 
corresponds to the grating-coupling SPR for the bonding mode [254].  Transmission of normally 
incident light through nanohole arrays is enhanced at the wavelengths that satisfy the SPR 






                                               (4) 
Here, P is the periodicity of the nanohole array, i and j are integers, εAu is the permittivity 
of gold (or whatever metal is used), and εd is the permittivity of the substrate adjacent to the metal. 
Effective coupling of light energy by designing nanohole arrays as per Equation 4 and defining 
metal layers of precise thickness can elicit a plasmonic signature in IDEs which has been 
extensively studied in this chapter for cell-based biosensing applications. 
Materials and Methods 




Figure 49 a. Schematic of nIDE device: A nanostructured polyacrylonitrile (PAN) layer is affixed to a glass substrate. A gold 
Interdigitated Electrode (IDE) structure is then patterned on top using a shadow mask. Finally, a 3D printed culture well coated 
with PDMS is attached to enable the IDE to be used with biological specimens. b. Process flow for spin-on nanoimprinting 
(SNAP) fabrication of PAN nanostructures. c. Fully assembled device being plated with polystyrene beads/ cardiomyocytes. 
Design of the nIDEs/pIDEs 
SolidWorks (Dassault Systems, Waltham, MA, USA) was used to design the interdigitated 
electrodes and the culture wells. A schematic of the nIDE device and its components are depicted 
in Figure 49a-c. The gold IDEs are designed to be 800 μm wide and 1 mm long with a pitch of 
either 1 mm, 250 µm, 100 µm, 64 µm, 10 µm, or 7 µm and a thickness of 30 nm, which gives a 
peak resonance wavelength between 620 nm and 750 nm [256].  The resonance peak red shifts as 
the thickness of the gold increases.  At times, there were issues with the e-beam shutter that led to 
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some thickness variation.  Additionally, the Thermionics e-gun power supply and controller were 
upgraded which seemed to consistently deposit a thickness to approximately 50 nm on the devices.  
The nanostructured chip is comprised of a 5 mm by 5 mm nanomachined PAN layer of 10 μm 
thickness with 50 nm nanoholes with a pitch of 200 nm. The fully assembled chip is designed to 
be 10 mm by 10 mm. 
The pitch of the electrodes was varied for each experiment.  Initially, we focused on 1 mm 
IDEs as our tool optimized to fabricate shadow masks at the time was the micromill which was 
not optimized for micrometer feature sizes in 2018. As a result, the shadow masking was switched 
to the laser micromachining tool. After optimizing the laser micromachining tool discussed in 
Chapter 2, we were able to fabricate a much wider variety of shadow mask pitches, so the natural 
progression of sizes came from starting at 1 mm and halving the value in succession.  This led to 
the use of the 250 µm, 64 µm, and 7 µm pitched electrodes.  From these results, we were able to 
determine that relating sizes by a factor of 10 would allow for more straightforward hypothesis 
formation and result comparison.  This led to the use of 1 mm, 100 µm, and 10 µm pitched 
electrodes. 
Fabrication of the Nanostructured Substrates 
The PAN nanostructures and planar PAN substrates used in this work were fabricated by 
Kowsik Sambath Kumar in Dr. Jayan Thomas’ Laboratory. 
Typical methods for the fabrication of nanostructures include methods like 
photolithography [257], e-beam lithography [258], and focused ion beam lithography [259]. Even 
though these methods offer high quality nanostructures, they involve tedious procedures, long 
processing time, limited scalability, and high cost. To achieve scalability, bottom-up approaches 
like self-assembly have been used, but they are limited to select materials, and pattern versatility 
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cannot be easily achieved using this approach. Sacrificial anodic aluminum oxide (AAO) templates 
for developing nanostructures are also widely used [260] for fabricating nanostructures; however, 
the sacrificial nature of AAO and the required use of strong chemical etchants places a serious 
limitation on this method. Several unconventional lithographic methods have been developed to 
circumvent the limitations posed by conventional lithographic techniques. Among these 
techniques, nanoimprinting lithography (NIL) [261] has attracted considerable attention. In NIL 
technique, many nanostructures can be replicated using an inexpensive NIL machine from a master 
mold. The feature size depends on the mold used to print the nanostructures. These nanostructures, 
pictured in Figure 50, can subsequently be used as substrates for various applications, including 
interdigitated electrodes. 
 
Figure 50 SEM of the mold used to fabricate the nanostructures. 
Recently, the Thomas group developed a spin-on nanoimprinting process (SNAP), shown 
in Figure 49b, to make nanostructures rapidly [262-264]. A polymer solution is prepared by 
dissolving 8 wt.% of polyacrylonitrile (PAN, Mw=150,000) in dimethylformamide and heated at 
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150 °C for 5 minutes. The PAN solution was then cooled and spin-coated on a pre-made Si mold 
with the inverse of the pattern to be printed. The PAN film was subsequently peeled-off from the 
mold, transferred to a glass substrate, and cured at 250°C. SNAP technique does not need high 
temperature, pressure, or any other force during the printing process. We have successfully 
developed nanoholes as small as 50 nm on PAN films to make IDEs. The silicon mold fabrication 
is a one-time event and several 100s of nanostructures can be printed using the SNAP process from 
the same master mold without any degradation [263]. 
Investigation of the Uniformity of the E-beam 
 Since thickness of the metal film deposited onto the nanostructured substrate is a key factor 
in the device’s plasmonic performance, it was decided to investigate the uniformity of the e-beam 
deposition.  Standard sized microscope cover slips (22 mm x 22 mm x 1 mm) from Fisher Scientific 
were placed on the 14 cm diameter sample holder to entirely cover the holder.  A 30 nm gold metal 
film as indicated by the quartz crystal monitor on the system was deposited onto the glass cover 
slips using electron beam evaporation (Thermionics, Hayward, CA).  Kapton® tape was affixed to 
the center of each slide to create a step for thickness measurement.  Thickness of the deposited 
metal was measured using a Dektak3 surface profilometer (Veeco, Plainview, NY). 
Fabrication of the nIDEs/pIDEs 
The initial 1 mm pitch IDE shadow masks were fabricated using the IDE designs by 
micromilling. A 90-degree T-8 Mill Tool (150 µm - 250 µm diameter; T-Tech, Peachtree Corners, 
GA, USA) was spun at 55,000 rpm in a T-Tech J5 Quick Circuit Prototyping Systems to micromill 
through an 80 μm thick stainless-steel sheet (Trinity Brand Industries, Countryside, Il, USA). 
All subsequent shadow masks were fabricated on 12.5 µm Kapton® (DuPont, Wilmington, 
DE) using 355 nm UV light at 50 Hz from a multimodal laser micromachining tool (QuikLaze 
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50ST2, New Wave Research, Portland, OR).  Masks were fabricated using two passes: the first to 
cut through the Kapton®, and the second to ensure that the shadow mask had smooth edges. 
The shadow masks were affixed to the 5 mm by 5 mm squares of nanomachined PAN atop 
a glass carrier substrate using Kapton® tape. A metal film comprising of 30 nm to 50 nm of gold 
(depending on whether the new or old e-beam system was used) was deposited onto the 
nanostructured PAN/glass substrate (Figure 49a) using electron beam evaporation (Thermionics 
Laboratory Inc., Hayward, California, USA) to metallize the interdigitated electrodes. The shadow 
mask was released carefully after the metallization step to reduce the damage to the underlying 
nanostructures.  
Initially, to package the nIDE device, a 3D printed (Form2, FormLabs, Somerville, MA, 
USA) culture well (10 mm inner diameter, 10 mm tall) was dip coated with polydimethylsiloxane 
(PDMS) in its entirety to improve biocompatibility of the printed resin material [265], and attached 
to the substrate using biocompatible 353ND epoxy (Epotek, Billerica, MA, USA) [266].  After 
determining that post-printing treatments could improve the biocompatibility of the 3D printer 
resin, culture wells were subsequently fabricated out of FormLabs High Temperature Resin 
(FLHTAM01) (FormLabs, Somerville, MA) and 3D printed in an Asiga MAX UV27 DLP (digital 
light processing) printer (Asiga, Sydney, Australia). After printing these culture wells were rinsed 
with IPA for 6 minutes, then UV cured for 6 minutes, and autoclaved for one hour.  These culture 
wells were subsequently affixed on to the PAN/glass substrates using biocompatible 353ND epoxy 
(Epoxy Technology, Billerica, MA).   
Lead wires of sanded copper were subsequently attached to the contact pads using an 
E2101 electrically conductive silver epoxy (Epotek, Billerica, MA, USA).  The silver epoxy was 
then covered with 353ND epoxy to ensure that the wires remained attached for the entire culture. 
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Polystyrene Bead Assay 
Prior to the cardiomyocyte assay, polystyrene (PS) latex beads of 1.1 μm particle size and 
concentration of 0.1 mg/ml in De-Ionized (DI) water (Sigma Aldrich, St. Louis, MO, USA) were 
used to emulate a cell-like material (Figure 49c). The aqueous suspension of PS latex beads was 
diluted with DI water in a ratio of 1:10 and the diluted solution was uploaded into a syringe and 
transferred to the culture well of the IDE device. The impedance measurements, using a frequency 
sweep from 10 Hz to 10 MHz, were performed on an IDE fabricated on a PAN nanomachined 
layer with a nanohole diameter of 50 nm and a pitch of 200 nm using a BODE Impedance Analyzer 
(Omicron Labs, Klaus, Austria). The reported impedance values are an average of two devices 
(N=2). 
Cell Culture 
 The protocols for the different cell cultures used in this chapter are described in this section. 
iCell Cardiomyocytes 
Human induced pluripotent stem cell (iPSC) differentiated cardiomyocytes (iCell 
Cardiomyocytes2, Cellular Dynamics, Madison, WI, USA) were used for cell studies. The iPSC 
cardiomyocytes were kept frozen in liquid nitrogen until they were cultured according to the 
manufacturer’s directions. To ensure that the cells adhere to the surface, the IDE devices were 
coated with 5 μL of 1:20 fibronectin (Sigma Aldrich, St. Louis, MO, USA) and Dulbecco’s 
Phosphate-Buffered Saline (DPBS) without Calcium and Magnesium (Gibco, Waltham, MA, 
USA) solution and placed in an incubator (37°C with 5% CO2) for one hour. Cells were thawed 
and counted to determine the density. This task was performed by mixing 100 μL of cells 
suspended in media with 0.4% Trypan Blue (Fisher Scientific, Waltham, MA, USA). A droplet of 
100 μL of this solution was subsequently applied to a glass hemocytometer and placed under a 
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10X microscope objective of a Nikon TE200 Inverted Fluorescence Microscope (Nikon, Tokyo, 
Japan) for observations. Live, unstained cells were counted in each of four sets of sixteen squares. 
The cell counts from each of the four sets of squares was averaged and multiplied by 10,000 and 
then multiplied by 5 to correct for the 1:5 dilution from the Trypan Blue addition. The fibronectin 
was aspirated, and the thawed cells were plated onto the nIDE surfaces (N=8) and two 6-well 
plates (control Polystyrene Plates from Corning Inc., Corning, NY, USA) and incubated for one 
hour (at 37°C with 7% CO2). A measured droplet of 300 μL of iCell Cardiomyocytes maintenance 
medium (Cellular Dynamics, Madison, WI, USA) was subsequently added to each of the eight 
culture wells and the controls. Full media changes occurred every other day.  Eight nIDE devices 
were densely plated with iCell cardiomyocytes with an average cell count of 310,500 cells per 
culture well. Each of the two 6-well plates (controls, N=12 wells) were plated with an average cell 
count of 50,000 cells per well for the experiment that used these cells.  
iCell Retinal Pigment Epithelial Cells 
 IDEs and nIDEs were prepared for cell culture by coating with 5 µL of 1:20 fibronectin 
(Sigma Aldrich, St. Louis, MO) and incubated for 1 hour.  To thaw the cells 25 mL of medium 
were warmed to room temperature. From this solution, 8 mL of medium were transferred into a 
sterile 15 mL centrifuge tube.  The cryovial containing the cells was thawed in a 37°C water bath 
for 3 minutes.  The cells were then transferred to the centrifuge tube containing the 8 mL of 
medium and the cryovial was rinsed with 1 mL of medium, which was then also transferred to the 
centrifuge tube.  The cells were centrifuged at 300 x g (~1,000 rpm) for 5 minutes.  The supernatant 
is aspirated and discarded.  The cells were then resuspended by adding 2 mL of medium to the 
centrifuge tube and gently mixing with the pipettor.  A selected quantity of 50,000 cells were 




 HL-1 cells were passaged from T75 flasks and resuspended according to the protocol in 
Chapter 3.  A selected quantity of 50,000 cells were seeded onto each IDE device and medium was 
exchanged daily. 
Biocompatibility Assay 
After one day in vitro (DIV01), nanostructured PAN was placed in the 6-well plate that 
was plated with approximately 50,000 cardiomyocytes. Biocompatibility studies were performed 
in the 6-well plates at DIV07 (days in vitro) to ensure that the nanostructured PAN surface was 
suitably compatible with the iCell cardiomyocyte cell line. This study was performed using the 
Promega Cell-Titer Glo Luminescent Cell Viability Assay Kit (Promega, Waltham, MA, USA). A 
volume of reagent measuring 0.5 mL, was added to each culture well and mixed for two minutes 
to induce lysis. The 6-well plate was incubated at room temperature for ten minutes to stabilize 
the subsequent measurement of a luminescent signal. Luminescence was recorded using a Tecan 
Infinite Pro 200 plate reader (Tecan, Männedorf, Switzerland) with the emission wavelength set 
at 500 nm, the excitation wavelength set at 365 nm, and an integration time of 10 seconds. The 
background and control measurements with only media in the culture well and media with cells in 
the culture well, respectively, were performed in addition to the nanopatterned PAN 
measurements. 
Impedance Measurements 
Electric cell-substrate impedance sensing (ECIS) was used to characterize the 
electrochemical properties of the cell-substrate interface. A low-voltage signal is applied to the 
nIDEs, which forms ionic currents in the cell culture medium. When cells are located on the nIDEs, 
these ionic currents are affected by the number, morphology, and adhesion of these cells [18]. 
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Impedance will gradually increase during the normal cell growth and proliferation process; thus, 
as more cells become attached to the nIDEs, an increase in electrical impedance is expected. 
For the impedance measurement, a full spectrum of the frequency range from 10 Hz to 10 
MHz, with an AC voltage perturbation of 20 mV, were scanned using BODE 100 impedance 
measurement station (Omicron Labs, Klaus, Austria) Figure 51a.  Impedance was normalized 
using the cell index (CI) calculation [20, 239], which is represented in Equation 5, where ΔZ is the 
change in real part of impedance from day to day and Zo is the background impedance on the nIDE. 
                                        CI = ∆Z ⁄ Zo             (5) 
Since drug-induced cardiotoxicity is of great interest with these biosensors, impedance 
measurements were additionally performed on the nIDEs with cultured iPSC cardiomyocytes 
utilizing different concentrations of norepinephrine (Sigma Aldrich, St. Louis, MO, USA) as a 
model drug compound. Concentrations of norepinephrine ranging from 0 μM to 250 μM were 
introduced to the culture well and impedance was measured to detect any changes due to the 
addition of the model drug. Cell index results from the model drug experiments were further 
normalized by using the percent cell index (%CI) [20, 239], represented in Equation 6, where CIo 
is the cell index with no norepinephrine and CIc is the cell index for a specific concentration of 
norepinephrine. 
%CI = CIc / CIo x 100                                            (6) 
Normalization of cell index calculations is an established calculation for such assays with 





Figure 51 a. Bode 100 impedance sensor schematic.  The IDE device is attached via alligator clips to the output and channel 2 
to allow for a series through impedance measurement. b. Agilent Cary 300 UV-Vis spectrometer used for plasmonic peak 
measurements.  Device is attached to a pinhole card and placed inside the chamber to determine peak.  The pinhole is shifted to 
multiple locations to allow for more comprehensive characterization. 
UV-Vis Measurements 
 UV-Vis spectroscopy measurements were performed using an Agilent Cary 300 (Agilent, 
Santa Clara, CA) UV-Vis Spectrometer (Figure 51b).  Absorbance spectra of IDEs and nIDEs both 
with and without cells were measured using a solid sample pinhole card positioned over one of the 
gold electrodes.  A planar PAN substrate on glass was used as the reference.  Scans were performed 
with a spectral bandwidth of 300 nm to 850 nm with an averaging time of 0.1 seconds (standard 
for the program).  Each scan was performed three times (N=3 measurements) and data was 
averaged for presentation. 
Light and Dark Impedance Measurements 
 Dark impedance measurements were performed in a completely dark room, apart from the 
light from a fully dimmed laptop screen needed to perform the measurements.  Light impedance 
measurements were performed in a normally lit lab with fluorescent lighting.  Laser impedance 
measurements were performed in a completely dark room, except for the dimmed laptop screen 
and the focused laser light.  Laser wavelengths used included 450 nm blue, 532 nm green, 625 nm 
red (all manufactured by Beam of Light Technologies, Clackamas, OR), and 650 nm red (OnPoint 
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Lasers Ltd., Minneapolis, MN).  All impedance settings used follow those provided in the prior 
section. 
Imaging 
 Images of the nIDEs were obtained with both a Nikon TS2 inverted microscope (Nikon, 
Tokyo, Japan) and a Keyence BZ-X800 All-in-One Confocal Microscope (Keyence, Tokyo, 
Japan).  Imaging of the nanostructures was performed using a Zeiss Ultra-55 FEG SEM 
(Oberkochen, Germany) and an Anasys NanoIR AFM (Bruker, Billerica, MA).  Live/Dead 
fluorescence imaging was also performed using the Keyence BZ-X800 All-in-One Confocal 
Microscope with the GFP and Texas Red filters.  Cells were fluorescently stained using an 
Invitrogen Live/Dead Cell Imaging Kit (Invitrogen, Carlsbad, CA) and allowed to incubate in the 
dark at room temperature.  Following this incubation time, the fluorescent stains were aspirated, 
and the cells were immediately imaged. 
Results and Discussion 
 This section presents the results and discussion from a series of nIDE/pIDE experiments 
that build on one another. 
1 mm nIDE vs. IDE 
To ensure that the suitable thickness of gold was consistently deposited on the 
nanostructured substrates due to the sensitivity of the SPR generation to thickness of the gold, we 
performed a test of the consistency of the electron beam deposition.  Figure 52 shows the results 
of this test.  The center of the sample plate gives the desired thickness of 30 nm, while a deviation 
from the desired thickness is seen in the outer areas of the sample plate.  The thickness of gold 




Figure 52 Measured thickness of metalized glass cover slides with steps.  The middle of the substrate holder gives the desired 
thickness, while the outer half gives slightly thinner samples with thicknesses ranging from 20 nm to 26 nm. 
Nanostructured IDEs (nIDEs) were successfully fabricated on the nanostructured PAN 
substrates. The nanostructures on the PAN substrate remained defined after the deposition of the 
gold IDE structure, as shown in Figure 53a. These SEM micrographs clearly depict the 
nanostructured PAN with repeatable “nanoholes” of approximately 50 nm in diameter and the mm-
scale gold electrodes defined on top of these “nanoholes”. The gold IDE structures measured 
within 99.37% of the designed dimensions representing an excellent translation from design. Fully 





  Human iPSC cardiomyocytes were successfully cultured onto the nIDEs as depicted in a 
sample image in Figure 53c. One can clearly observe a mat of cells on top of the IDEs in the 
images collected with transmitted light microscopy. The cell viability assay confirmed that the 
nanostructured PAN substrate was cytocompatible for cell culture with iCell Cardiomyocytes2. 
The other components of the nIDE (gold, PDMS, and 353ND epoxy), have previously been 
established to be cytocompatible with cardiomyocytes [265, 266]. Fluorescence levels were well 
above the background fluorescence, which indicates that most of the cultured cells were viable, as 
shown in Figure 53d. Quantitatively, the nanostructured PAN and control wells (N=6 for both 
types), both showed a fluorescence of nearly 40,000 RFU with a low standard deviation of 
approximately 3000 RFU, which depicts excellent cytocompatibility performance (97.01% ± 





Figure 53 a. SEM image of electrodes deposited on top of the nanostructured PAN layer with zoomed in SEM images of the printed 50 nm PAN nanohole structures. Scales from 
left to right are 250 μm, 1 μm, and 180 nm, respectively. b. Completed nIDE device with culture well and wires attached. c. Human iPSC Cardiomyocytes cultured on 1 mm pitch 
nIDE at DIV01.  The cardiomyocytes completely cover the surface of the IDE.  d. Biocompatibility assay results - The nanostructured PAN substrate shows similar (97.01% ± 




Figure 54 a. Representative full spectrum impedance measurements - The nIDEs with cardiomyocytes cultured on them show an increased impedance from the nIDEs that only 
have an aqueous medium. In addition, as the cells proliferate an increase in impedance is observed. b. Variation of the Cellular Index (CI) of the cells cultured on the nIDEs for 18 
days: it was observed that the CI of the nIDEs increased over time as expected because the cell coverage of the nIDE increases over time. The calculated mean value of N=8 wells 
of nIDEs is represented by the square bullet point. A comparison to the data from Himmel et. al. tracks the CI changes observed in our assay. Since our IDE pitch is 100X the 
pitch demonstrated by the IDE from Himmel, we believe the presence of the nanostructures result in improvement in device sensitivity. c. CI and d. %CI for norepinephrine 
experiment: Mean values for N=6 is depicted with a square bullet point. The CI and %CI both show an exponential decrease, with excellent fits given by their R2 values of 0.974 
and 0.954, respectively, as the concentration of norepinephrine increases because the cells are dying due to the dosage of the drug.  This causes a departure from the impedance of 
the nIDE with no norepinephrine added.
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Figure 54a depicts an example of the raw, full spectrum impedance data for polystyrene 
beads, iCell Cardiomyocytes2 (average value of N=8 at two specific days: DIV10 and DIV18), and 
aqueous media clearly delineating the three analytes. Further, this figure shows that the impedance 
of the nIDEs with cells (110.19 kΩ at 1 kHz for DIV10 and 243.21 kΩ at 1kHz for DIV18) and 
polystyrene beads (96.53 kΩ at 1 kHz) were higher than the nIDE with just aqueous medium (27.37 
kΩ at 1 kHz), which follows expected trends due to the modification of the ionic currents due to 
the presence of cells and the PS beads [14]. In addition, Figure 54a demonstrates a decrease in 
impedance from an IDE without a nanostructured substrate to that of the nanostructured IDE, both 
in aqueous media.  Looking closely at the ECIS for the two sample DIV measurements (N=8), 
they demonstrated an increase in impedance as the days in vitro increased. The cell index also 
demonstrated an increase as the days in vitro increased (Figure 54b). This is an expected result as 
reported by Himmel, et. al. The morphological changes in the cells leads to an increased impedance 
as the cell coverage increases; and the cell coverage will inherently increase as the cells grow over 
time [14, 267]. This result held until the assay was terminated at DIV18. To our knowledge, we 
are the first to report this result with 1 mm pitch nIDEs over a period of 18 days with human 
cardiomyocytes and a similar trend using a commercial system with 10 μm pitch IDEs on a glass 
substrate fabricated with a complex photolithographic technique involving several steps [267] is 
reported by Himmel, Hu et. al., and Lamore et. al. [14, 16, 268] Our devices are 100X larger than 
these three other studies but report similar CI increases from cell growth (CI=1.1 on DIV10 
increasing to CI equal to approximately 7-8 on DIV17).  It is believed the comparable performance 
is due to the nanoscale structure patterned onto the substrate of the nIDEs. As a result, we believe 
that the nIDE shows an increased sensitivity compared to commercial IDE systems, which have 
an electrode gap that is 100X smaller. It is believed that this increase in sensitivity is due to the 
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increased electrode surface area provided by the nanoholes.  When surface area increases, 
capacitance increases; thus, impedance decreases giving greater sensitivity [92, 231, 243, 269], as 
shown in Equation 7, where C is the capacitance, ɛo is the vacuum permittivity, ɛr is the relative 
permittivity of the electrolyte, A is surface area of the electrode, d is electrode gap, and Z is 
impedance. 
                                    C = (εo εr A) / d ∝ 1 / Z                 (7) 
The model drug experiment with norepinephrine showed a decrease in both cell index 
(from CI=2.34 at 0 μM of norepinephrine to CI=1.13 at 256 μM norepinephrine) (Figure 54c) and 
percent cell index (86.91% at 0 μM of norepinephrine to 48.88% at 256 μm norepinephrine) 
(Figure 49d) with increasing concentrations of norepinephrine (mean of N=7). Both the CI and 
%CI for norepinephrine addition demonstrate exponential behavior with excellent fits of 0.974 and 
0.954, respectively. This is expected because as the cardiomyocytes are exposed to higher 
concentrations of norepinephrine, more cells are expected to die from the exposure [231]. As a 
result, there was less active cellular coverage, which lowers the impedance, CI, and %CI. 
 
Figure 55 Fabricated device images: a. Fully packaged nIDE device with culture well and wires attached. b. SEM of gold IDEs 
on the nanostructured PAN substrate. c. AFM of an electrode.  The nanoholes remain visible after gold deposition, which 
provides an increased electrode surface area. 
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Plasmonic Resonance of the Nanostructured Substrate 
A fully packaged IDE with a culture well and wires attached is shown in Figure 55a.  Figure 
55b shows an SEM image of the gold electrodes on the nanostructured PAN surface and Figure 
55c shows an AFM image of the electrode to show that the integrity of the nanostructures remains 
after repeated use of the mold.  Impedance values measured at 1 kHz were converted to cell index 
(CI) and showed a trend of increasing CI and improved sensitivity for smaller gaps (Figure 56). 
Additionally, the CI of the IDEs on the nanostructured substrate was approximately 100-1000X 
greater than that of the IDEs on the non-nanostructured substrate. This indicates enhanced 
sensitivity due to the nanostructuring. UV-Vis measurements showed a 12 nm to 22 nm red-shift 
in the plasmonic peak of the devices with the addition of cells (Figure 57). Variation in peak 
intensity and shift can potentially be attributed to the thickness of gold, number of cells, and cell-
nanostructure interactions demonstrating possibilities for cellular and sub-cellular manipulation.  
Figure 58 shows the retinal pigment epithelial cells growing on the 250 µm nanostructured IDE 
surface at DIV04. This expected growth helps confirm the biocompatibility of these PAN 
nanostructures for retinal pigment epithelial cells. 
 
Figure 56 Average cellular index (CI=[Zo-Zc]/Zo) for N=3 devices showing an increase in CI for nanostructured versus 
standard IDEs.  CI is a tool for normalizing the impedance, as every device will not be identical.  CI results follow the expected 
pattern of smaller electrode gaps having larger cellular indices.  This indicates that smaller electrode gaps, as well as the 








Figure 57 UV-Vis measurements for the devices.  All nIDE devices show a red shift in the plasmonic peak, as indicated, with the addition of cells, as expected.  The standard IDEs 
show no plasmonic peak.  Variations in the plasmonic peaks are expected due to varying thickness the gold electrodes, as well as the cell-electrode interactions. a. 7 µm, b. 62 µm, 




Figure 58 Human retinal pigment epithelial cells (DIV04) cultured onto a 250 µm electrode gap nanostructured IDE device.  
The cells grew on the devices, as expected, thus demonstrating good biocompatibility with the device materials. 
Individual Contributions of Enhancement Modes 
For the remainder of the experiments, HL-1 cells were used.  They combine the quick mat-
like growth of the retinal pigment epithelial cells with the electrophysiological characteristics of 
iCell cardiomyocytes.  Figure 59a shows a schematic depicting the different enhancement modes 
that were hypothesized and studied, while Figure 59b shows HL-1 cells growing on an IDE at 
DIV03 showing typical mat-like growth.  Impedance values were converted to CI (cellular index), 
which is a method to normalize impedance as we have discussed before in this chapter [90] and 
show a clear trend of increasing CI and improved sensitivity for smaller electrode gap widths or 
pitches.  
 
Figure 59 a. IDE sensitivity can be increased via nanostructuring of the substrate, designing smaller electrode gap widths, or 
probing with incident light of a wavelength equal to that of the plasmonic resonance peak. b. HL-1 cells on an IDE at 3 DIV.  





Figure 60 Cellular index measurements a. Cellular index (CI) measurements: decreased electrode gap width and the presence of 
nanostructures on the substrate cause an increase in the cellular index. b. Comparison of the various device measurements. All 
graphs are an average of N=3 devices. 
This depicts the geometric trend with a calculated dramatic enhancement of 137,499X for 
the design extremities (Figure 60a). The CI for the IDEs cultured on the nanostructured surface 
reaches a maximum of 144.59X when compared to IDEs on the planar PAN at 5 DIV. Several 
orders of magnitude enhanced sensitivity from geometric and nanostructuring modes of the 
electrodes is observed (Figure 60b). The increased surface areas due to nanostructuring are 
calculated as 68.3%, 45.5%, and 21.3% for 10 µm, 100 µm, and 1 mm electrode gap widths, 
respectively. Since the measurements were all performed in ambient light, it was hypothesized that 
fluorescent lighting might have an emission peak near that of the plasmonic resonance peak for 30 
nm gold nanostructures (approximately 720 nm), which it does [270].  To isolate this mode, 
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impedance measurements were performed in the dark for one of the designs (1 mm IDEs on 
nanostructured and planar substrates).  An increase in CI for the dark measurements was elicited, 
but not to the same magnitude as that of the measurements performed in ambient light, resulting 
in a maximum of 6X (Figure 61a). We suspect that further enhancement would be observed if the 
incident light were of a discrete wavelength, as supported by the reflectivity measurement in Figure 
61b. Individual contributions to the enhanced sensitivity from all three modes is further depicted 
in Figure 61c for a subset of the designs. 
 
Figure 61 a. 1 mm cellular index measurements.  The cellular index for the dark measurement falls between the IDE and nIDE 
performed in ambient light.  This means that the fluorescent lighting is likely inducing surface plasmon resonance and causing an 
increase in impedance. b. The reflectivity measurement performed here shows the extinction of the nanohole substrate with and 
without cells.  A 30 nm shift of the peak due to the change of the surface refractive index from the presence of the cells on the 
nanohole structures can be seen.  This is an important characteristic of plasmonics. c. Comparison of different enhancements. 
Sensitivity can be increased by substrate nanostructuring, decreasing electrode gap width, introducing the proper wavelength of 
light, or a combination of these as desired in various cell-based biosensing assays. 
To further examine the enhancement contribution from SPR elicitation with lasers in the 
range of 650-720nm, discrete wavelengths of incident light were tested.  Figure 62a shows the 
difference between the cellular indices of the IDEs and pIDEs procured in the dark.  The CI of the 
pIDE is higher than that of the IDE, as expected from prior experiments.  Figure 62b compares the 
enhancement from each of the laser wavelengths when compared to the dark pIDE measurement.  
It is clear that as the laser wavelength nears the plasmonic peak of 720 nm [146], the sensitivity 
enhancement factor for CI is increased.  Comparing this to the data in Figure 61 shows that by 
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choosing a wavelength close to the plasmonic peak, the CI can be increased by two orders of 
magnitude over that of diffuse incident light exposure, or three orders of magnitude of no light 
exposure. 
 
Figure 62 a. 1 mm cellular index measurements.  The cellular index for the pIDE exceeds that of the IDE, as expected from 
previous work shown in this chapter.  b. Comparison of enhancement due to different laser wavelengths.  The 450 nm blue and 
532 nm green lasers increase the cellular index when focused on the pIDE, but not much more than unfocused ambient light, as 
shown in Figure 12a.  The 635 nm red laser increases the cellular index further, but the 650 nm laser demonstrates the greatest 
enhancement of cellular index likely due to its proximity to the plasmonic peak of the substrate. 
Figure 63a shows cells growing on a pIDE electrode prior to termination of DIV05.  Figure 
63b and c show live/dead images of cells on an IDE and a pIDE, respectively.  Here the green cells 
(fluorescing at 488 nm due to dye uptake) are alive, while the red cells (fluorescing at 570 nm due 
to dye uptake) are dead.  Clearly, the cells remained largely viable over the course of the five-day 
assay.  Some cell morphology change is expected due to phototoxicity from the various laser 
experiments [271].  Table 5 provides the maximum sensitivity enhancement in CI observed for 
each of the enhancement modes.  While decreasing the electrode gap width provides the most 
dramatic sensitivity enhancement, it also becomes more and more difficult to produce 
microelectrodes as the pitch is reduced below 10µm.  Therefore, combining these enhancement 
modes provides the greatest advantage.  By producing the small (by the fabrication methods 
presented within this dissertation) electrode gap widths on nanostructured substrates and 
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measuring the impedance in a dark room while shining a discrete wavelength of laser light onto 
the electrode surface in order to produce surface plasmon resonance, one is able to take advantage 
of all of the sensitivity enhancement modes depicted in this chapter to achieve a highly sensitive 
benchtop fabricated plasmonic interdigitated electrode. 
 
Figure 63 Optical Images of Cells on IDEs/pIDEs. a. Phase contrast image of HL-1 cells on pIDE electrode at DIV05. b. 
Live/Dead image of HL-1 cells on an IDE at DIV05.  Most cells are living (green), while only a few cells are dead (red). c.  
Live/Dead image of HL-1 cells on a pIDE at DIV05.  As with the IDE, most of the cells are living (green), while few are dead 
(red). 
Table 6 Maximum enhancement for each enhancement mode of the pIDEs 
Mode Maximum Sensitivity Enhancement 
Geometric 137,499X 
Nanostructuring 144.59X 
Ambient Lighting 6X 
Discrete Laser Wavelength 1804.92X 
 
Conclusions 
This study reports for the first time the development of IDEs patterned onto nanostructured 
PAN substrates using rapid micro/nanofabrication technologies. The resulting nanostructured 
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IDEs (or nIDEs) demonstrated excellent design to device (99.37% translation of design features) 
and biocompatibility of 97.01% ± 2.15% with respect to iCell cardiomyocytes2 control. The nIDEs 
were developed as a tool for rapid screening of toxins with an impedance metric and they 
demonstrated an impedance (110.19 kΩ at 1 kHz for DIV10 and 243.21 kΩ at 1 kHz for DIV18) 
that was higher than the IDEs with just an aqueous medium (27.37 kΩ at 1 kHz) which was used 
as a control. In addition, the nIDEs with cells showed increased impedance as evidenced by a Cell 
Index (CI) increase from 0 to 7.7 with increasing days in vitro of cell culturing. This result is as 
predicted because impedance should increase as cell coverage increases because of the cell-
electrode interaction. Long term cell culture (18 days) was demonstrated with iCell 
Cardiomyocytes2, and most significantly, an improvement in device performance when fabricated 
on nanostructured substrates (100X larger electrode gaps than commercial systems) was 
demonstrated through cellular index calculations. Finally, the cardiotoxicity testing utility of our 
devices was successfully demonstrated with the expected response of decreased cellular index 
from 2.34 to 1.13 in response to increased concentrations of a model drug, norepinephrine. 
Additionally, it was demonstrated through UV-Vis spectroscopy that the nanostructured 
substrate exhibits a plasmonic peak.  This means that an additional plasmonic resonance sensing 
mode can be activated by exposing the nIDE surface to the correct wavelength of light (and hence 
a pIDE).  It was subsequently shown that the sensitivity of micron and millimeter scale IDEs can 
be enhanced via three individual alterations: two physical, and one optical: (1) increasing 
microelectrode surface area through fabrication on a nanostructured substrate; (2) decreasing the 
electrode gap width; and (3) probing the electrode surface with specific wavelengths of light. These 




CHAPTER 6: CONCLUSIONS & FUTURE WORK 
Conclusions 
 In this dissertation, the development of several novel methods of patterning inorganic and 
organic materials and biocompatibility approaches for HL-1 cells and 3D printed materials, as well 
as the subsequent application of these methods to the development of biosensors and lab-on-a-chip 
devices, specifically Interdigitated Electrodes (IDEs), on non-traditional plasmonic polymer 
substrates as well as the deployment of these methods to enhance precision cellular placement on 
traditional glass MEA substrates has been presented. It was hypothesized that a combination of 
facile microfabrication techniques and patterning technologies on traditional and non-traditional 
substrates would increase the sensitivity and selectivity of sensor platforms such as these by 
several orders of magnitude, and even potentially introduce new modalities for cell-based 
biosensing.  This was demonstrated using pIDEs where minimum enhancement of 6X was 
observed via exposure to incident ambient light alone not to mention 6 orders of improved 
sensitivity enhancements by combining multiple modalities.  The biological functionality of these 
new IDEs was demonstrated through the use of a variety of cell cultures: cardiac, stem cell, and 
endothelial cells to study the growth, proliferation, modes of increasing sensitivity, and response 
to various compounds in vitro (outside the body). 
Future Work 
 Given the results of this dissertation research, a gateway for a wide array of future work, 
has been opened and these expected directions are provided below. 
Laser Micromachining 
Laser micromachining has been utilized for a wide variety of two-dimensional materials in 
our laboratory.  The natural progression of exploring the utility of this fabrication technique would 
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be to attempt to micromachine non-planar materials.  Additionally, further decreasing the spot 
sizes that can be machined is paramount. Such an exploration would be particularly beneficial if 
processes can be reduced to the nanoscale widths. 
Extrusion Bioprinting 
 The spot sizes able to be printed are still larger than ideal.  The aim to get spots down to 
100 µm will continue in future work on this aspect of the dissertation.  Further exploring 3D printed 
micro-nozzles is a viable solution to reducing spot sizes, as well as looking into surface 
functionalization to decrease the drop contact diameter.  Additionally, branching out from 2D 
cellular structures to 3D cellular constructs could potentially be explored, as cellular scaffolds are 
of great interest in the bioprinting field. 
nIDE/pIDE 
 Probing a cell laden pIDE with the correct wavelength of laser light, cell layers can be 
encouraged to lift from the substrate surface, which could be interesting to the tissue engineering 
application of the plasmonic IDE. Further low-level laser/LED light could optically stimulate the 
cells. Potential probing of the pIDE with a low-power infrared laser for an extended period 
(approximately 40 minutes or more) to determine if tissue lifting occurs could be explored.  This 
could be useful for tissue origami applications. Such plasmonic-based stimulation could provide a 
brand-new way for non-invasive cellular stimulation technologies. 
pMEA 
 Full development and testing of a pMEA needs to be explored.  The nanostructured 
substrates need to become more uniform to ensure that we can interface them with our modified 
Axion MUSE system.  A realistic insulation solution needs to be found.  This solution could be 
something as simple as an adhesive (e.g. Medco/Polyethylene Terephthalate (PET) layer).  This is 
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an example of a solution that can first be laser micromachined to have openings in the appropriate 
areas for the electrodes and then carefully adhered to the pMEA surface.  Another solution could 
be parylene deposition and suitable laser ablation.  We had initially intended to try this along with 
SiO2 but were unable to do so due to extenuating circumstances due to COVID-19 since UCF does 
not have a parylene deposition system. We had planned to go to UF or Georgia Tech to perform 
these experiments. SiO2 is notoriously difficult to ablate, so perhaps a different material would 
produce better results.  Additional electrodes could be added outside of the nanostructured area to 









Development of a Plasmonic Microelectrode Array (pMEA) 
Introduction 
Microelectrode array (MEA) biosensors have been the standard in electrogenic cell 
measurements since the 1970s [272].  Electrogenic cells, such as cardiomyocytes and neurons, 
generate momentary changes in potential across the cell membrane.  These changes in potential 
are called action potentials and can be thought of as electrical pulses.  These electrical pulses can 
be recorded by the means of microelectrodes.  MEA sensors involve a layer of patterned insulation 
atop a layer of patterned metal on a substrate, such as a glass or polymer wafer.  While this 
technology has proliferated the marketplace, several issues with their microfabrication still exist.  
One such example is that the fabrication technology for most MEAs is silicon or glass-based; thus, 
it is highly reliant on expensive cleanroom-based processes, such as photolithography and 
chemical etching, which require advanced know-how [243, 272-276].  Alternative fabrication 
techniques for micro- and nanostructuring that allow for the same sensitivity, feature sizes and 
functionalities as cleanroom fabricated MEAs on a variety of substrates are required.  Another 
such example is that impedance-based measurements using MEAs are time consuming, as each 
electrode must be measured individually.  While this is not necessarily an issue for simple device 
characterization tasks, one could not perform such measurements on a cell laden device quickly 
and accurately enough to maintain the proper environment for ideal cell viability (humidity, 
temperature, etc.) [276].   
Commercial MEA systems that allow for more comprehensive device measurements exist 
[214], but typically require biosensor devices to be of specific form factors; thus, the ability to 
fashion a device to needed specifications would be necessary for less tedious measurement 
processes.  Axion BioSystems [277] makes a commercial form factor-specific MEA system. Their 
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proprietary software allows for the automatic application of filters for specific electrophysiological 
phenomenon and stimulation. Axion offers MEAs in a high throughput format of a multi-well 
plate. Multichannel Systems [278] also manufactures commercial MEA systems and typically in 
a low throughput, research scale, single well format. Their systems allow for the use of MEAs with 
varying number of electrodes. These systems are non-form specific to a point, label-free, high 
sensitivity, and allow for cells to be followed in real time. However, addition of other modalities 
of sensing are important in these systems and are just beginning to be evaluated. 
 In this appendix chapter, we present the development of a plasmonic microelectrode array 
(pMEA).  Our lab has successfully used non-cleanroom-based techniques to fabricate a variety of 
MEAs in the past few years [145, 147, 148, 165]; however, the ability to reduce the signal-to-noise 
ratio (SNR) of the electrodes to enhance sensitivity and developing other modalities of sensing are 
under evaluation. In this appendix, we explored the preliminary processing-based integration of 
plasmonics with MEA technologies. 
Hypothesis 
One of the challenges for the plasmonic architectures we have demonstrated in the previous 
chapters is the fragile nanostructures. It is hypothesized that through careful metallization and 
insulation choices and processing conditions along with the use of facile microfabrication 
technologies discussed in the previous chapters, the integrity of the nanostructures can be 
preserved. 
Additionally, it is hypothesized that by combining the nanostructured PAN substrate with 
an MEA, a reduction in SNR can be achieved; thus, giving the pMEA a greater device sensitivity.  
Also, by probing the device with light, a surface plasmon resonance can be induced, which 
introduces an additional sensing modality. 
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Materials and Methods 
 Shadow masks were designed in SolidWorks (Dassault Systems, Velizy-Villacoublay, 
France).  Shadow masks were subsequently fabricated via laser micromachining on 12.5 µm thick 
Kapton® using the UV setting at 50 Hz and a 50 µm by 50 µm spot size. 
 Gold microelectrodes of approximately 50 nm thickness were deposited onto the 
nanostructured substrates using electron beam evaporation.  Silicon dioxide (SiO2) was 
subsequently deposited using electron beam evaporation atop the gold electrodes layer as an 
insulation layer.  The SiO2 insulation layer deposited was approximately 300 nm thick.  The SiO2 
insulation layer was subsequently ablated using the green and UV settings to expose the electrodes. 
These test conditions for micro-ablation of the SiO2 layer are shown in Table 6. 
Table 7 pMEA laser ablation test conditions 
pMEA SiO2 Insulation Laser Ablation Tests 
Sample Electrode Objective 
Spot 
Size Wavelength Energy Density 
1 1 10X 50 µm2 532 nm 0.027 mJ/µm2 
 2 10X 50 µm2 532 nm 0.0054 mJ/µm2 
 3 10X 50 µm2 532 nm 0.0044 mJ/µm2 
 4 10X 50 µm2 532 nm 0.0031 mJ/µm2 
 5 10X 50 µm2 532 nm 0.0022 mJ/µm2 
2 1 50X 25 µm2 355 nm 0.0088 mJ/µm2 
 2 50X 25 µm2 355 nm 0.0044 mJ/µm2 
 3 50X 25 µm2 355 nm 0.0018 mJ/µm2 
3 1 10X 45 µm2 532 nm 0.0029 mJ/µm2 
 2 10X 45 µm2 532 nm 0.0024 mJ/µm2 
 3 10X 45 µm2 532 nm 0.0019 mJ/µm2 
 4 10X 45 µm2 532 nm 0.0014 mJ/µm2 
  
Ablated electrodes were then imaged using the Keyence BZ-X800 All-in-One Confocal 
Microscope (Tokyo, Japan) in the standard brightfield imaging modality.  Select electrodes were 
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also examined via the AFM (nanoIR2, Anasys, Billerica, MA) in both tapping and contact mode 
in order to characterize the micro-ablation. 
Results and Discussion 
 The pMEA consists of 100 µm on a side microelectrodes (square size) with a 400 µm pitch, 
as shown in Figure 64a.  In this test design 16 electrodes were arranged in a 4x4 array.  The contacts 
were designed to be rather large (1 mm x 0.5 mm) to interface with our modified Axion MUSE 
system. 
  
Figure 64 Schematic of a. pMEA design and b. pMEA insulation ablation mask. 
 Figure 64b shows the schematic for the pMEA insulation shadow mask.  This shadow mask 
is aligned over the electrodes during laser micromachining of the insulation to ensure that only the 
electrodes area is ablated. 
 Due to an issue with the silicon mold for the fabrication of the spin on nanostructures, the 
effective nanostructure chip area was reduced from 5 mm x 5 mm to 4 mm x 4 mm.  The initial 
metallization and SiO2 ablation tests were performed with this chip size.  The metallized pMEA 
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structure was smaller than the glass slide onto which the PAN and the PAN nanostructures are 
immobilized (Figure 65), as the glass slides used by the Thomas group vary each time.  This 
condition would need to be consistent over time to interface effectively with the modified Axion 
MUSE during pMEA fabrication. 
 
Figure 65 Metallized pMEA.  This is one of the first iterations, so some shadowing can be seen from the shadow mask. 
 After gold deposition as depicted in the photo micrograph in Figure 65, silicon dioxide was 
deposited as an insulation layer.  The deposition rate of SiO2 in the e-beam was not able to be 
maintained at a constant rate, so the thickness and the surface roughness of the deposited materials 
needed to be tested.  Additionally, it was necessary to determine whether the SiO2 filled in the 
nanostructures.  Figure 66 shows an AFM of a pMEA electrode with gold and silicon dioxide.  The 
SiO2 deposited evenly despite the rather uncontrollable deposition rate suggested by the quartz 
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crystal during deposition; however, the nanostructures became filled during the deposition process 
which is clear from this AFM image.  This filling could invalidate the nanostructure and hence the 
fabrication of the pMEA microelectrodes. As a result, this first attempt was not successful and 
alternate insulate layers (e.g. atomic layer deposition, aluminum oxide, parylene etc.) need to be 
considered for the pMEA process. 
 
Figure 66 AFM of a pMEA electrode with SiO2 insulation.  The SiO2 filled the nanostructures resulting in a completely smooth 
surface. 
 
Figure 67 Example of an ablated electrode. 
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 Figure 67 shows the one of the series of micrographs captures for the laser ablation of the 
silicon dioxide insulation layer as per the conditions provided in Table 6.  From this micrograph, 
one can see that the laser micromachining conditions resulted in the entirety of gold being removed 
from the electrode surface along with the SiO2 insulation layer at even the lowest energy density.  
All the other images taken for the microelectrode definition look similar or worse with the ablation 
of the entire structure.  
Conclusions 
 Shadow masks for a pMEA device and for the laser ablation of insulation were successfully 
designed in CAD software.  These shadow masks were successfully laser micromachined to allow 
for gold deposition.  Insulation definition using e-beam evaporation of SiO2 was attempted, 
followed by the laser micro-ablation of the SiO2 insulation.  A variety of low-power conditions 
were tested in the laser micromachining process to attempt to preserve the integrity of the 
nanostructured PAN layer.  Despite our best efforts, laser micromachining of SiO2 does not seem 
to be a viable insulation solution for the realization of pMEAs. 
 
Makerspace Microfabrication of a Stainless-Steel 3D Microneedle Electrode Array (3D MEA) 
on a Glass Substrate for Simultaneous Optical & Electrical Probing of Electrogenic Cells 
 NBSS REU student Paola M. Morales Carvajal designed and fabricated a stainless-steel 
3D MEA on a glass substrate with the guidance of lab members Avra Kundu and Chuck Didier.  
This paper has been accepted to RSC Advances and will be published in December 2020 [94]. 
 After the 3D MEA had been fabricated, the ability of the device to capture 
electrophysiological activity needed to be determined in order to test the device from design to 
biological data generation.  Figure 68 shows the device and the results of biological data capture.  
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Figure 68a and Figure 68b shows the fully packaged 3D MEA device interfacing with the Axion 
BioSystems MUSE electrophysiology system.  Figure 68c shows the noise from one of the 3D 
MEA electrodes.  Figure 68d shows HL-1 cells (plated and maintained per the protocol in Chapter 
3) on the 3D MEA at 2 DIV.  Figure 68e shows the cardiac beats as they appear in a screen capture 
from the AxIS software on the Axion MUSE, while Figure 68f provides a post-processed, averaged 
plot of repeatable single beats from the HL-1 cells cultured on the 3D MEA. 
 
Figure 68 3D MEA device: a. and b. The fully packaged 3D MEA device interfacing with the Axion MUSE. c. Representative 
noise plot of one of the microelectrodes of the 3D MEA. d. HL-1 cells after 2 DIV. e. Cardiac beats as they appear on the AxIS 










Plotting Axion Raw Data 
 Axion MUSE files are output in raw data file form.  MATLAB is the best tool to plot and 
analyze this raw data. The MATLAB code for this data plotting is denoted below: 
Data=AxisFile('FILENAME.raw').DataSets.LoadData, ('C2','34',[0 90]); %Loads the first 90 
seconds of data for electrode 34  
[t,v]=AllData{3,2,3,4}.GetTimeVoltageVector; %Get time and voltage vectors  
plot(t,v) %Plot the voltage vs time data  
 
AllData=AxisFile('NeuralDemoData_SpikeFile.spk').DataSets.LoadData; %Loads spike data 
spikes=AllData{2,8,4,4}(1:5).GetVoltageVector; %Get the voltage data from the first 5 spikes of 
electrode 44 
time=AllData{2,8,4,4}(1).GetTimeVector; %Get the time vector from the first spike  
plot_time=time-repmat(time(1),size(time)); %Shift the time vector back so it starts from zero  
plot(plot_time,spikes); %Plot the 5 spike waveforms overlaid 
 
Plotting Raw Impedance Data 
 Raw impedance data from the BODE 100 is comprised of hundreds of data points.  Using 
MATLAB to directly plot this data simplifies the process. The MATLAB code for this data 
plotting is denoted below: 
imp=dlmread('DATA.txt'); %Load real impedance data file 
x1 = imp(:,1); 
y1 = imp(:,2); 
Re = 200:10:300; %4700:100:44000; 
Rct = 15000; %100:100:5000; 
Cdl = 0.0020*10^-8; %10^-9:10^-8:10^-6; 
freq = 100:100:10^7; %Set frequency range 
for k=1:1:length(Re) 
Z(:,k) = Re(k) + 1.; 
RealZ = real(Z); 
ImagZ = imag(Z); 
% AngleZ = phase(Z) 
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